1
|
Vecsey-Nagy M, Varga-Szemes A, Emrich T, Zsarnoczay E, Nagy N, Fink N, Schmidt B, Nowak T, Kiss M, Vattay B, Boussoussou M, Kolossváry M, Kubovje A, Merkely B, Maurovich-Horvat P, Szilveszter B. Calcium scoring on coronary computed angiography tomography with photon-counting detector technology: Predictors of performance. J Cardiovasc Comput Tomogr 2023; 17:328-335. [PMID: 37635032 DOI: 10.1016/j.jcct.2023.08.004] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 04/25/2023] [Revised: 07/10/2023] [Accepted: 08/05/2023] [Indexed: 08/29/2023]
Abstract
INTRODUCTION Obtaining accurate coronary artery calcium (CAC) score measurements from CCTA datasets with virtual non-iodine (VNI) algorithms would reduce acquisition time and radiation dose. We aimed to assess the agreement of VNI-derived and conventional true non-contrast (TNC)-based CAC scores and to identify the predictors of accuracy. METHODS CCTA datasets were acquired with either 120 or 140 kVp. CAC scores and volumes were calculated from TNC and VNI images in 197 consecutive patients undergoing CCTA. CAC density score, mean volume/lesion, aortic Hounsfield units and standard deviations were then measured. Finally, percentage deviation (VNI - TNC/TNC∗100) of CTA-derived CAC scores from non-enhanced scans was calculated for each patient. Predictors (including anthropometric and acquisition parameters, as well as CAC characteristics) of the degree of discrepancy were evaluated using linear regression analysis. RESULTS While the agreement between TNC and VNI was substantial (mean bias, 6.6; limits of agreement, 178.5/145.3), a non-negligible proportion of patients (36/197, 18.3%) were falsely reclassified as CAC score = 0 on VNI. The use of higher tube voltage significantly decreased the percentage deviation relative to TNC-based values (β = -0.21 [95%CI: 0.38 to -0.03], p = 0.020) and a higher CAC density score also proved to be an independent predictor of a smaller difference (β = -0.22 [95%CI: 0.37 to -0.07], p = 0.006). CONCLUSION The performance of VNI-based calcium scoring may be improved by increased tube voltage protocols, while the accuracy may be compromised for calcified lesions of lower density. The implementation of VNI in clinical routine, however, needs to be preceded by a solution for detecting smaller lesions as well.
Collapse
Affiliation(s)
- M Vecsey-Nagy
- Heart and Vascular Center of Semmelweis University, Budapest, Hungary; Department of Radiology and Radiological Science, Medical University of South Carolina, Charleston, SC, USA
| | - A Varga-Szemes
- Department of Radiology and Radiological Science, Medical University of South Carolina, Charleston, SC, USA
| | - T Emrich
- Department of Radiology and Radiological Science, Medical University of South Carolina, Charleston, SC, USA; Department of Diagnostic and Interventional Radiology, University Medical Center of the Johannes Gutenberg-University, Mainz, Germany
| | - E Zsarnoczay
- Department of Radiology and Radiological Science, Medical University of South Carolina, Charleston, SC, USA; Medical Imaging Center of Semmelweis University, Budapest, Hungary
| | - N Nagy
- Medical Imaging Center of Semmelweis University, Budapest, Hungary
| | - N Fink
- Department of Radiology and Radiological Science, Medical University of South Carolina, Charleston, SC, USA; Department of Radiology, University Hospital, LMU Munich, Munich, Germany
| | - B Schmidt
- Siemens Healthcare GmbH, Forchheim, Germany
| | - T Nowak
- Siemens Healthcare GmbH, Forchheim, Germany
| | - M Kiss
- Siemens Healthcare GmbH, Forchheim, Germany
| | - B Vattay
- Heart and Vascular Center of Semmelweis University, Budapest, Hungary
| | - M Boussoussou
- Heart and Vascular Center of Semmelweis University, Budapest, Hungary
| | - M Kolossváry
- Gottsegen National Cardiovascular Center, Budapest, Hungary; Physiological Controls Research Center, Budapest, Hungary
| | - A Kubovje
- Medical Imaging Center of Semmelweis University, Budapest, Hungary
| | - B Merkely
- Heart and Vascular Center of Semmelweis University, Budapest, Hungary
| | | | - B Szilveszter
- Heart and Vascular Center of Semmelweis University, Budapest, Hungary.
| |
Collapse
|
2
|
Teszak T, Assabiny A, Kiraly A, Tarjanyi Z, Parazs N, Szakal-Toth Z, Kugler S, Szabolcs Z, Fintha A, Muzes G, Vago H, Jermendy A, Edes I, Merkely B, Sax B. Extensive Cardiac Allograft Vasculitis and Concurrent Constrictive Pericarditis 23 Years after Heart Transplantation. J Heart Lung Transplant 2023. [DOI: 10.1016/j.healun.2023.02.480] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 04/05/2023] Open
|
3
|
Teszak T, Assabiny A, Kiraly A, Tarjanyi Z, Parazs N, Szakal-Toth Z, Kugler S, Hartyanszky I, Szabolcs Z, Suhai F, Edes I, Fintha A, Merkely B, Sax B. Multivessel Epicardial Coronary Artery Thrombosis after Heart Transplantation. J Heart Lung Transplant 2023. [DOI: 10.1016/j.healun.2023.02.1230] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 04/05/2023] Open
|
4
|
Szécsi B, Sinkó R, Gereben B, Oleszka M, Losoncz E, Gál J, Radovits T, Merkely B, Székely A. RELEVANCE OF DEIODINASE ENZYMES IN HEART TRANSPLANT – PRELIMINARY STUDY. J Cardiothorac Vasc Anesth 2022. [DOI: 10.1053/j.jvca.2022.09.056] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/05/2022]
|
5
|
Zhubi Bakija F, Bagyura Z, Fabian A, Ferencz A, Lakatos B, Ujvari A, Kiss L, Csobay-Novak C, Jermendy A, Szelid Z, Soos P, Kovacs A, Merkely B. Long-term prognostic value of left atrial longitudinal strain in a low-risk community-based cohort. Eur Heart J 2022. [DOI: 10.1093/eurheartj/ehac544.055] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Numerous studies established the significant predictive value of left ventricular (LV) global longitudinal strain (GLS) on adverse clinical outcomes in various cardiac diseases. Despite the well-known importance of left atrial (LA) mechanics in diastolic function, data are scarce regarding the prognostic power of LA longitudinal strain and its potential added value in the risk stratification of a low-risk population.
Accordingly, our aim was to determine the long-term prognostic importance of 2D speckle-tracking echocardiography-derived peak atrial longitudinal strain (PALS) in a community-based screening sample comprising of low-risk adult individuals.
Three hundred fourteen volunteers were retrospectively identified from a population-based screening program (mean age 62±11, 58% female) with a median follow-up of 9.5 years. All subjects who participated in the screening program underwent 2D echocardiography to measure LV volumes and ejection fraction (EF), LV GLS and PALS, as well as low-dose cardiac CT to determine the Agatston score. The primary endpoint was all-cause mortality.
Thirty-nine subjects (12.4%) met the primary endpoint. Subjects with adverse outcome had significantly decreased LV GLS (dead vs. alive; −19.2±4.3 vs. −20.6±3.5%, p<0.05) and PALS (32.3±12.0 vs. 41.8±14.2%, p<0.001), whereas LV EF did not show a difference between the two groups (51.1±7.0 vs. 52.1±6.2, %, p=NS). By multivariable Cox regression analysis, PALS (hazard ratio 0.970 [95% CI: 0.943–0.998], p<0.05) and Agatston score were independently associated with all-cause mortality, whereas GLS was not (hazard ratio 1.008 [95% CI, 0.919–1.105], p=NS). Furthermore, we dichotomised the population based on PALS values using a guideline-directed cut-off of 39%. In subjects with lower PALS values, the risk of all-cause mortality was almost 2.5 times higher than in subjects with PALS values above 39% (hazard ratio 2.499 [95% 1.334–4.682], p<0.05) as shown on the Kaplan-Meier curve (Figure 1).
Beyond the assessment of LV EF and LV GLS, PALS offers incremental value in cardiovascular risk stratification in a community-based cohort. PALS was found to be the only significant and independent predictor of long-term mortality among other echocardiographic functional parameters. Our results emphasize the importance of a thorough evaluation of LA mechanics even in a low-risk population.
Funding Acknowledgement
Type of funding sources: None.
Collapse
Affiliation(s)
- F Zhubi Bakija
- Semmelweis University Heart and Vascular Center , Budapest , Hungary
| | - Z Bagyura
- Semmelweis University Heart and Vascular Center , Budapest , Hungary
| | - A Fabian
- Semmelweis University Heart and Vascular Center , Budapest , Hungary
| | - A Ferencz
- Semmelweis University Heart and Vascular Center , Budapest , Hungary
| | - B Lakatos
- Semmelweis University Heart and Vascular Center , Budapest , Hungary
| | - A Ujvari
- Semmelweis University Heart and Vascular Center , Budapest , Hungary
| | - L Kiss
- Semmelweis University Heart and Vascular Center , Budapest , Hungary
| | - C Csobay-Novak
- Semmelweis University Heart and Vascular Center , Budapest , Hungary
| | - A Jermendy
- Semmelweis University Heart and Vascular Center , Budapest , Hungary
| | - Z Szelid
- Semmelweis University Heart and Vascular Center , Budapest , Hungary
| | - P Soos
- Semmelweis University Heart and Vascular Center , Budapest , Hungary
| | - A Kovacs
- Semmelweis University Heart and Vascular Center , Budapest , Hungary
| | - B Merkely
- Semmelweis University Heart and Vascular Center , Budapest , Hungary
| |
Collapse
|
6
|
Perge P, Sallo Z, Petrovic N, Piros K, Nagy KV, Osztheimer I, Merkely B, Geller L, Szegedi N. Early rapid local impedance drop is associated with acute lesion efficacy during pulmonary vein isolation using a novel contact force sensing catheter. Eur Heart J 2022. [DOI: 10.1093/eurheartj/ehac544.478] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Introduction
The predictive role of adequate local impedance drop in lesion formation using a novel contact force sensing ablation catheter for pulmonary vein isolation was recently described. The purpose of our study was to assess the temporal characteristics of local impedance drop during ablation and its correlation with acute lesion efficacy.
Methods
Point-by-point radiofrequency pulmonary vein isolation was performed in power-controlled mode with 50 W energy setup. The efficacy of applications was determined by pacing along the circular ablation line. The successful lesions were estimated if loss of capture was achieved. Local impedance, contact force and catheter position data of the applications with 5 msec resolution was analysed. The local impedance of successful and unsuccessful applications was compared at baseline and 2, 4, 6, 8, 10 and 12 sec time points, respectively. We characterized the local impedance for each time point with the mean of the 5 impedance value closest in time. The sum of the range of catheter position in x, y and z dimensions was also compared to assess stability during the application.
Results
643 applications were analysed, 559 were successful and 84 were unsuccessful. Mean contact force was lower (p=0.04), while the sum of catheter position range was higher (p<0.001) in unsuccessful applications during ablation, suggesting worse catheter stability. The successful applications were characterized by a higher baseline local impedance (p<0.001), and a larger local impedance drop at the 2, 4, 6, 8 and 10 sec time points (p<0.001, for all). In case of unsuccessful applications, after a moderate but significant drop from baseline to the 2 sec time point (baseline: 153 Ohm vs 2 sec: 145 Ohm, p<0.001) local impedance did not change further over time (2 sec: 145 Ohm vs 12 sec: 143 Ohm; p=0.99). While on the other hand, in case of successful applications, the local impedance further decreased significantly up to the 10 sec timepoint, respectively (baseline: 161 Ohm vs 2 sec: 150 Ohm vs 10 sec: 141 Ohm, p<0.001 for all). The optimal cut-point for the local impedance drop indicating unsuccessful application was <9 Ohms at the 4 second time point [AUC=0.73 (0.67–0.76), p<0.001]. Failing to reach at least 9 Ohm impedance drop at the 4 second time point predicted unsuccessful applications [(p<0.001; OR: 3.82 (2.34–6.25)].
Conclusion
Rapid and enduring drop of the local impedance may predict effective lesion formation, while slightly changing or unchanged local impedance is associated with unsuccessful applications. In case of a moderate local impedance drop during the first 4 seconds of radiofrequency application, it might be reasonable to stop the application and start a new one after catheter repositioning.
Funding Acknowledgement
Type of funding sources: None.
Collapse
Affiliation(s)
- P Perge
- Semmelweis University, Heart and Vascular Center , Budapest , Hungary
| | - Z Sallo
- Semmelweis University, Heart and Vascular Center , Budapest , Hungary
| | - N Petrovic
- Semmelweis University, Heart and Vascular Center , Budapest , Hungary
| | - K Piros
- Semmelweis University, Heart and Vascular Center , Budapest , Hungary
| | - K V Nagy
- Semmelweis University, Heart and Vascular Center , Budapest , Hungary
| | - I Osztheimer
- Semmelweis University, Heart and Vascular Center , Budapest , Hungary
| | - B Merkely
- Semmelweis University, Heart and Vascular Center , Budapest , Hungary
| | - L Geller
- Semmelweis University, Heart and Vascular Center , Budapest , Hungary
| | - N Szegedi
- Semmelweis University, Heart and Vascular Center , Budapest , Hungary
| |
Collapse
|
7
|
Olah A, Barta BA, Ruppert M, Sayour AA, Bottlik O, Merkely B, Schilling O, Radovits T. Proteomic analysis of exercise-induced hypertrophy reveals sex-related mitochondrial differences mediated by AMPK. Eur Heart J 2022. [DOI: 10.1093/eurheartj/ehac544.2943] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Abstract
Abstract
Background
Regular physical activity results in characteristic structural and functional changes in the heart, which are collectively referred to as the athlete's heart. However, the extent of exercise-induced left ventricular (LV) hypertrophy and functional changes show significant differences between men and women, the molecular background of which is not fully elucidated.
Objective
The aim of this study was to provide a proteomic characterization of long-term, intense exercise-induced LV myocardial hypertrophy in a rat model, with a focus on sex-related differences.
Methods
Our rats were divided into trained (FEx) and control female (FCo) as well as trained (MEx) and control male (MCo) groups. In the trained groups, athlete's heart was induced by a 12-week swimming protocol. Myocardial hypertrophy was confirmed by echocardiography and functional adaptation by pressure-volume analysis. Proteomic measurements based on liquid chromatograph-coupled mass spectrometry were performed on proteins isolated from our LV myocardial samples.
Results
Echocardiography and post-mortem myocardial mass showed significant LV hypertrophy in both sexes, which was more pronounced in female animals (tibial length normalized LV muscle mass: + 17.4% MEx vs. MCo, + 31.0% FEx vs. FCo). LV contractility increased to the same extent in both sexes. Relative expression of 3074 proteins were determined by proteomics. There was a significant change in expression of 229 proteins in males and 599 in females compared to the level of same-sex controls. Based on our gene ontological analysis, physiological LV remodeling in females is characterized by increased expression of proteins in mitochondrial function (cellular respiration and fatty acid oxidation) and biogenesis, whereas in males, proteins that bind to the actin cytoskeleton is primarily increased. Further investigation revealed that the quantity of AMP-activated protein kinase (AMPK) and sirtuin 3 (SIRT3) was increased only in female animals.
Conclusions
Our data suggests that physiological LV hypertrophy resulting from regular, balanced exercise is associated with sex-specific changes in the myocardial proteome. The main differences might be associated with different regulation of mitochondrial function and biogenesis, related to AMPK pathway. Our results contribute to the understanding of the development of physiological myocardial hypertrophy.
Funding Acknowledgement
Type of funding sources: Private grant(s) and/or Sponsorship. Main funding source(s): Bolyai János Research Scholarship (BO/00837/21) to OANational Research, Development and Innovation Office (NKFIH) K135076 to B.M.
Collapse
Affiliation(s)
- A Olah
- Semmelweis University, Heart and Vascular Center , Budapest , Hungary
| | - B A Barta
- Semmelweis University, Heart and Vascular Center , Budapest , Hungary
| | - M Ruppert
- Semmelweis University, Heart and Vascular Center , Budapest , Hungary
| | - A A Sayour
- Semmelweis University, Heart and Vascular Center , Budapest , Hungary
| | - O Bottlik
- Semmelweis University, Heart and Vascular Center , Budapest , Hungary
| | - B Merkely
- Semmelweis University, Heart and Vascular Center , Budapest , Hungary
| | - O Schilling
- University of Freiburg, Institute of Surgical Pathology , Freiburg , Germany
| | - T Radovits
- Semmelweis University, Heart and Vascular Center , Budapest , Hungary
| |
Collapse
|
8
|
Komlosi F, Tokodi M, Vamosi P, Toth P, Szegedi N, Osztheimer I, Perge P, Piros K, Abraham P, Sallo Z, Szijarto A, Kovacs A, Merkely B, Nagy VK, Geller L. Machine learning based risk stratification of patients undergoing ventricular tachycardia ablation. Eur Heart J 2022. [DOI: 10.1093/eurheartj/ehac544.695] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Background
Monomorphic ventricular tachycardia (VT) is a potentially life-threatening condition. Although radiofrequency catheter ablation represents an effective treatment method for many of these patients, significant variability is observed in postprocedural mortality, which is attributable to multiple factors, including the high burden of comorbidities. Therefore, there is a great demand for an accurate risk stratification system.
Purpose
We sought to implement a machine learning pipeline to predict 1-year all-cause mortality in patients undergoing VT ablation.
Methods
For 265 consecutive patients who underwent VT ablation at our center, we retrospectively collected demographics, medical history, cardiovascular risk factors, laboratory results, echocardiographic measurements, and VT ablation-related parameters. To predict 1-year all-cause mortality based on these features, several supervised machine learning models were trained and evaluated using 5-fold cross-validation. We applied a recursive elimination technique to identify the optimal subset of input features. The area under the receiver operating characteristic curve (AUC) with a 95% confidence interval (CI) was calculated to quantify the models' performance. We also identified the most important predictors of mortality using Shapley values. As the final step, we used topological data analysis to discern and visualize patient subgroups with different mortality risk.
Results
57 (22%) patients died during the 1-year follow-up period. In predicting all-cause mortality, the best performance was achieved by a random forest model utilizing 18 input features [AUC: 0.73 (95% CI: 0.68–0.78)]. This model significantly outperformed other previously published risk scores such as the I-VT [AUC: 0.63 (95% CI: 0.55–0.70), p<0.001 vs. random forest] or the PAINESD [AUC: 0.63 (95% CI: 0.55–0.71), p=0.009 vs. random forest]. The most important predictors of mortality were mitral E-wave deceleration time, cardiac resynchronization therapy, age, electrical storm, and hemoglobin concentration. In the topological network created based on the 18 input features of the best-performing random forest model, we could identify five patient subsets with different clinical characteristics and 1-year mortality rates (Figure 1).
Conclusions
Our machine learning model could efficiently predict 1-year all-cause mortality in patients undergoing VT ablation. Thus, it could facilitate the prompt identification of high-risk patients and the personalization of treatment and follow-up strategies, ultimately leading to improved outcomes.
Funding Acknowledgement
Type of funding sources: Public grant(s) – National budget only. Main funding source(s): National Heart Program, as part of the National Research, Development and Innovation Fund of HungaryThematic Excellence Programme of the Ministry for Innovation and Technology in Hungary
Collapse
Affiliation(s)
- F Komlosi
- Semmelweis University , Budapest , Hungary
| | - M Tokodi
- Semmelweis University , Budapest , Hungary
| | - P Vamosi
- Semmelweis University , Budapest , Hungary
| | - P Toth
- Semmelweis University , Budapest , Hungary
| | - N Szegedi
- Semmelweis University , Budapest , Hungary
| | | | - P Perge
- Semmelweis University , Budapest , Hungary
| | - K Piros
- Semmelweis University , Budapest , Hungary
| | - P Abraham
- Semmelweis University , Budapest , Hungary
| | - Z Sallo
- Semmelweis University , Budapest , Hungary
| | - A Szijarto
- Semmelweis University , Budapest , Hungary
| | - A Kovacs
- Semmelweis University , Budapest , Hungary
| | - B Merkely
- Semmelweis University , Budapest , Hungary
| | - V K Nagy
- Semmelweis University , Budapest , Hungary
| | - L Geller
- Semmelweis University , Budapest , Hungary
| |
Collapse
|
9
|
Drobni Z, Gong J, Raghu V, Zafar A, Gongora C, Quinaglia T, Suero-Abreu G, Gilman H, Gao X, Sullivan R, Merkely B, Reynolds K, Neilan T. Association between immune checkpoint inhibitors and vascular endothelial growth factor targeted therapy with cardiovascular events. Eur Heart J 2022. [DOI: 10.1093/eurheartj/ehac544.2585] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
Abstract
Abstract
Background
The use of immune checkpoint inhibitors (ICI) has been associated with a 3-fold higher risk for cardiovascular events as compared to cancer patients who did not receive ICI. Therapies targeting vascular endothelial growth factor (VEGF) have also been associated with a wide range of cardiovascular events. The combination use of ICIs and VEGF inhibitors is currently approved as a treatment for patients with renal-cell carcinoma, hepatocellular carcinoma, non-small cell lung cancer, and endometrial cancer. Data are lacking whether the combination of ICIs and VEGF-targeted therapy is associated with an additional increase in cardiovascular events.
Purpose
To evaluate whether the combination use of ICI and VEGF targeted therapies are associated with a higher risk of cardiovascular events as compared to ICI therapy alone, we performed a retrospective matched case-control study.
Methods
Cases received both ICI and VEGF-targeted therapy (n=157), and control patients (n=157) only received ICI therapy. The primary outcome was a composite of cardiovascular events (myocardial infarction, coronary revascularization, ischemic stroke, deep venous thrombosis, and pulmonary embolism). Patients were censored at time of first event or at last date of follow up. Cox proportional hazard regression analysis was performed to calculate hazard ratio (HR) with 95% confidence interval (CI), counting only the first cardiovascular event.
Results
Baseline characteristics for the cases and controls are shown in Table 1. Overall cases (combination ICI and VEGF inhibitor) and controls (ICI alone) were not different with respect to age, type of cancer, and a prior history of any cardiovascular event. Cases received more ICI cycles as compared to controls (median of 7 [4–17] cycles vs. 4 [2–10] cycles, P<0.001). Cases also had a longer follow-up time (334 [127–663] days vs. 201 [60–564] days, P=0.008) as compared to the control group. As compared to ICI alone, a similar risk for a composite cardiovascular event was observed in those who received both ICI and VEGF-targeted therapy (HR, 0.70 [95% CI, 0.39–1.25]; P=0.23, Table 1). In total, 21/157 patients had a composite cardiovascular event among the cases, who received the combination of ICI and VEGF inhibitor (9 DVT, one MI, 9 PE, two ischemic strokes) as compared to 25/157 among the controls, who received ICI alone (14 DVT, 3 MI, 7 PE, one ischemic stroke). The median time to event was not different between the two groups (126 [98–260] days vs. 145 [28–205] days, P=0.47).
Conclusion
We found that among 157 patients who received a combination of ICI and VEGF-targeted therapy and 157 matched control patients who only received ICI therapy, the risk for cardiovascular events was not different between the two groups.
Funding Acknowledgement
Type of funding sources: Public grant(s) – EU funding.
Collapse
Affiliation(s)
- Z Drobni
- Semmelweis University , Budapest , Hungary
| | - J Gong
- Mass General Hopital (MGH), Cardiovascular Imaging Research Center (CIRC), Department of Radiology and Division of Cardiology , Boston , United States of America
| | - V Raghu
- Mass General Hopital (MGH), Cardiovascular Imaging Research Center (CIRC), Department of Radiology and Division of Cardiology , Boston , United States of America
| | - A Zafar
- Mass General Hopital (MGH), Cardiovascular Imaging Research Center (CIRC), Department of Radiology and Division of Cardiology , Boston , United States of America
| | - C Gongora
- Mass General Hopital (MGH), Cardiovascular Imaging Research Center (CIRC), Department of Radiology and Division of Cardiology , Boston , United States of America
| | - T Quinaglia
- Mass General Hopital (MGH), Cardiovascular Imaging Research Center (CIRC), Department of Radiology and Division of Cardiology , Boston , United States of America
| | - G Suero-Abreu
- Mass General Hopital (MGH), Cardiovascular Imaging Research Center (CIRC), Department of Radiology and Division of Cardiology , Boston , United States of America
| | - H Gilman
- Mass General Hopital (MGH), Cardiovascular Imaging Research Center (CIRC), Department of Radiology and Division of Cardiology , Boston , United States of America
| | - X Gao
- Massachusetts General Hospital, Division of Oncology and Hematology, Department of Medicine , Boston , United States of America
| | - R Sullivan
- Massachusetts General Hospital, Division of Oncology and Hematology, Department of Medicine , Boston , United States of America
| | - B Merkely
- Semmelweis University , Budapest , Hungary
| | - K Reynolds
- Massachusetts General Hospital, Division of Oncology and Hematology, Department of Medicine , Boston , United States of America
| | - T Neilan
- Mass General Hopital (MGH), Cardiovascular Imaging Research Center (CIRC), Department of Radiology and Division of Cardiology , Boston , United States of America
| |
Collapse
|
10
|
Achim A, Lacko D, Huttl A, Csobay-Novak C, Csavajda A, Sotonyi P, Merkely B, Nemes B, Ruzsa Z. Roadsaver versus Wallstent for carotid artery stenting: a retrospective cohort study. Eur Heart J 2022. [DOI: 10.1093/eurheartj/ehac544.1995] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Introduction
Carotid artery stenting (CAS) is an established alternative option to surgical treatment for carotid artery stenosis, 3 main contemporary types of stent design being used for this purpose (open-, closed-cell, mesh-covered stents). So far, no definite conclusions have been reached on the superiority of any of those devices for CAS. With its new double-mesh design, the Roadsaver stent has emerged as an attractive option for use in CAS, aiming to further reduce neurological events. However, its efficacy as compared to other stents, such as Wallstent, has not been thoroughly explored. We thus aimed to compare the clinical outcomes of Roadsaver and Wallstent for use in CAS.
Methods
This retrospective cohort study included patients who underwent CAS and received either Wallstent or Roadsaver stent at a tertiary centre (centre A) in a Central European country during 2009–2021, and another tertiary centre (centre B) in the same country during 2016–2019. Patients with incomplete baseline clinical records were excluded. Patients were followed up for one year at centre A, and for 30 days at centre B. The primary outcomes were 30-day and 1-year major adverse cardiac or cerebrovascular events (MACCE), defined as a composite of myocardial infarction, stroke, and cardiovascular mortality. The secondary outcome was 30-day bradycardia. Baseline covariates were balanced between groups using inverse probability treatment weighting. Thirty-day outcomes were compared using logistic regression with odds ratio (OR) as the summary statistic, and 1-year MACCE was compared using Cox regression with hazard ratio (HR) as the summary statistic.
Results
In total, 982 patients were identified. After applying the exclusion criterion, 770 patients were included in the analysis (482 patients from centre A and 288 patients from centre B; 287 (37.3%) females, mean age 68±8 years old), of which 589 (76.5%) received Wallstent and 181 (23.5%) received Roadsaver. There was no loss to follow-up. Twenty-three (3%) patients had MACCE by 30 days, and 16 (3.3%) of those who completed one-year follow-up had MACCE by one year. No significant differences in MACCE were observed between the two stents at 30 days (OR 0.697 [0.374, 1.300], p=0.256) and one year (HR 0.512 [0.126, 2.073], p=0.348). Roadsaver was associated with significantly higher odds of 30-day bradycardia (OR 5.391 [4.089, 7.108], p<0.0001), which remained significant after adjusting for the number of post-dilatations performed (p<0.0001). Additionally, Roadsaver was associated with significantly lower risk of one-year MACCE among symptomatic patients (N=184; HR 0.131 [0.024, 0.723], p=0.020; Figure 1), but not among asymptomatic patients (N=298; HR 1.774 [0.332, 9.490], p=0.503).
Conclusion
There was no short- and long-term hazard difference between the 2 types of stent designs, however Roadsaver may be superior to Wallstent among symptomatic patients.
Funding Acknowledgement
Type of funding sources: None.
Collapse
Affiliation(s)
- A Achim
- University of Medicine and Pharmacy of Cluj Napoca, Institutul Inimii , Cluj Napoca , Romania
| | - D Lacko
- Semmelweis University Heart and Vascular Center , Budapest , Hungary
| | - A Huttl
- Semmelweis University Heart and Vascular Center , Budapest , Hungary
| | - C Csobay-Novak
- Semmelweis University Heart and Vascular Center , Budapest , Hungary
| | - A Csavajda
- Bacs-Kiskun Hospital , Kecskemet , Hungary
| | - P Sotonyi
- Semmelweis University Heart and Vascular Center , Budapest , Hungary
| | - B Merkely
- Semmelweis University Heart and Vascular Center , Budapest , Hungary
| | - B Nemes
- Semmelweis University Heart and Vascular Center , Budapest , Hungary
| | - Z Ruzsa
- University of Szeged, Invasive Cardiology , Szeged , Hungary
| |
Collapse
|
11
|
Dohy Z, Szabo L, Pozsonyi Z, Csecs I, Toth A, Suhai FI, Czimbalmos C, Szucs A, Kiss AR, Becker D, Merkely B, Vago H. The role of cardiac magnetic resonance-based feature-tracking strain analysis in the differential diagnosis and prognostic assessment of patients with left ventricular hypertrophy. Eur Heart J 2022. [DOI: 10.1093/eurheartj/ehac544.272] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Background
Cardiac magnetic resonance (CMR) examinations have an essential role in the diagnosis of myocardial diseases with left ventricular (LV) hypertrophy; however, limited data are available from CMR-based feature-tracking strain analysis in this patient population. The aim of our study was to investigate the differential diagnostic and prognostic importance of feature-tracking strain analysis in patients with LV hypertrophy caused by myocardial disease.
Methods
We investigated 404 patients who underwent CMR examination and were diagnosed with myocardial disease causing LV hypertrophy. Hypertrophic cardiomyopathy (HCM) was detected in 330 patients, cardiac amyloidosis (CA) in 46 patients, Fabry disease (FD) in 12 patients, and endomyocardial fibrosis (EMF) in 16 patients. LV strain analysis was performed with feature-tracking. Global longitudinal (GLS), circumferential (GCS) and radial (GRS) LV strain parameters were measured. Strain values for the six basal, six midventricular, and five apical segments were averaged to obtain regional longitudinal and circumferential strain values (basal LS, midventricular LS, apical LS, basal CS, midventricular CS, apical CS). The apex-to-base regional LS and CS ratios were calculated as apical LS/basal LS and apical CS/basal CS, respectively. To assess global dyssynchrony, mechanical dispersion (MD) was measured. The all-cause mortality of the patients was analyzed.
Results
In the differentiation of CA from HCM, GLS had the highest sensitivity with a cutoff of more than −23%, and basal LS and basal CS had the highest specificity with a cutoff of more than −16% and −38%, respectively (p<0.001). FD patients had the lowest longitudinal and circumferential MD values, meaning that compared to that of other patients with LV hypertrophy, global dyssynchrony is least pronounced in this patient population (p<0.01). EMF patients had impaired global and regional CS and the lowest apex-to-base CS and LS ratios. CA patients had the highest apex-to-base CS and LS ratios, suggestive of apical sparing (p<0.001). CA patients had the worst prognosis; the significant independent predictors of mortality were a diagnosis of CA, the LV stroke volume index and basal LS (p<0.01).
Conclusions
Myocardial diseases with left ventricular hypertrophy have remarkable differences in CMR-based strain characteristics which can be helpful in the differential diagnosis and provides incremental information on adverse outcomes.
Funding Acknowledgement
Type of funding sources: Public grant(s) – National budget only. Main funding source(s): Development and Innovation Fund of Hungary, Ministry for Innovation and Technology in Hungary
Collapse
Affiliation(s)
- Z Dohy
- Semmelweis University Heart and Vascular Center , Budapest , Hungary
| | - L Szabo
- Semmelweis University Heart and Vascular Center , Budapest , Hungary
| | - Z Pozsonyi
- Semmelweis University , Budapest , Hungary
| | - I Csecs
- Semmelweis University Heart and Vascular Center , Budapest , Hungary
| | - A Toth
- Semmelweis University Heart and Vascular Center , Budapest , Hungary
| | - F I Suhai
- Semmelweis University Heart and Vascular Center , Budapest , Hungary
| | - C Czimbalmos
- Semmelweis University Heart and Vascular Center , Budapest , Hungary
| | - A Szucs
- Semmelweis University Heart and Vascular Center , Budapest , Hungary
| | - A R Kiss
- Semmelweis University Heart and Vascular Center , Budapest , Hungary
| | - D Becker
- Semmelweis University Heart and Vascular Center , Budapest , Hungary
| | - B Merkely
- Semmelweis University Heart and Vascular Center , Budapest , Hungary
| | - H Vago
- Semmelweis University Heart and Vascular Center , Budapest , Hungary
| |
Collapse
|
12
|
Ruppert M, Barta BA, Sayour AA, Olah A, Nagy D, Balint T, Benke K, Schilling O, Merkely B, Radovits T. Pressure overload and volume overload-induced chronic heart failure are associated with characteristic left ventricular myocardial proteomic alterations. Eur Heart J 2022. [DOI: 10.1093/eurheartj/ehac544.2958] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Abstract
Abstract
Introduction
Hemodynamic overload induces pathological remodeling of the left ventricle (LV) and eventually heart failure (HF). The two types of chronic hemodynamic stress, namely pressure overload (PO) and volume overload (VO) evoke characteristically different functional and structural alterations in the myocardium. Nevertheless, whether PO- and VO-induced HF are also associated with distinct LV proteomic alterations has not been investigated yet.
Aim
Hence, we thought to perform a proteomic analysis on LV myocardial samples from rat models of PO- and VO-induced HF.
Methods
PO–induced HF was evoked by transverse aortic constriction (TAC). VO–induced HF was established by creating an aortocaval fistula (ACF). Age-matched sham-operated animals served as controls for TAC (ShamT) and ACF (ShamA), respectively. Pressure-volume (P-V) analysis, echocardiography, histology and quantitative real-time PCR were carried out to provide a detailed characterization of the two HF models. Peptides obtained via the digestion of myocardial proteins with trypsin and LysC were labeled with isobaric tags (TMT16) and measured with LC-MS/MS in a bottom-up explorative proteomic approach. Differential expression and gene ontology enrichment analysis (GO:BP) was carried out on summarized protein reporter ion intensities.
Results
In both the TAC and ACF groups, presence of typical signs and symptoms of HF (dyspnea at rest, fatigue, ascites) increased lung-to-tibial length ratio and elevated LV natriuretic peptide mRNA expression levels confirmed the development of advanced HF. Furthermore, the TAC model was associated with massive wall thickening, concentric LV hypertrophy (LVH), marked interstitial fibrosis and substantially impaired active relaxation and passive filling (slope of end-diastolic P-V relationship: 0.103±0.015 vs. 0.023±0.003mmHg/μl, TAC vs. ShamT, P<0.001). In contrast, the ACF model was predominantly characterized by LV dilatation, eccentric LVH, moderate fibrosis and severely reduced LV contractility (slope of end-systolic P-V relationship: 0.5±0.1 vs. 2.3±0.3mmHg/μl, ACF vs. ShamA, P<0.001). Proteomic analysis revealed that out of the 4691 identified and quantified proteins, 1404 and 913 have shown upregulation, while 1359 and 886 downregulation in the TAC and ACF groups respectively compared to their corresponding sham groups. GO:BP analysis has indicated that the downregulation of mitochondrion organization, ATP metabolic processes and oxidative phosphorylation and the upregulation of actin cytoskeleton organization were the most profound alterations in the TAC model. In contrast, the ACF model was associated with robust downregulation of fatty acid oxidation and upregulation of endocytosis, defense and immune response on the proteomic level.
Conclusions
PO and VO-induced advanced HF are not only associated with characteristically different functional and structural remodeling but also with distinct LV proteomic alterations.
Funding Acknowledgement
Type of funding sources: Public grant(s) – National budget only. Main funding source(s): National Research, Development and Innovation Office (NKFIH) of Hungary
Collapse
Affiliation(s)
- M Ruppert
- Semmelweis University Heart and Vascular Center , Budapest , Hungary
| | - B A Barta
- Semmelweis University Heart and Vascular Center , Budapest , Hungary
| | - A A Sayour
- Semmelweis University Heart and Vascular Center , Budapest , Hungary
| | - A Olah
- Semmelweis University Heart and Vascular Center , Budapest , Hungary
| | - D Nagy
- Semmelweis University Heart and Vascular Center , Budapest , Hungary
| | - T Balint
- Semmelweis University Heart and Vascular Center , Budapest , Hungary
| | - K Benke
- Semmelweis University Heart and Vascular Center , Budapest , Hungary
| | - O Schilling
- University Hospital of Freiburg, Institute of Surgical Pathology , Freiburg , Germany
| | - B Merkely
- Semmelweis University Heart and Vascular Center , Budapest , Hungary
| | - T Radovits
- Semmelweis University Heart and Vascular Center , Budapest , Hungary
| |
Collapse
|
13
|
Kuthi L, Schwertner W, Veres B, Merkel E, Behon A, Masszi R, Kovacs A, Osztheimer I, Molnar L, Zima E, Geller L, Kosztin A, Merkely B. The impact of frailty index on long-term outcome in CRT patients. Eur Heart J 2022. [DOI: 10.1093/eurheartj/ehac544.1007] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Abstract
Abstract
Background
Frailty is a complex clinical syndrome associated with ageing and comorbidities resulting from multiple organ impairment by losing homeostatic reserves and increased vulnerability to physiological decompensation. Frailty can be measured by quantifying the “vulnerability status” by the range of comorbidities.
Purpose
We assessed the long-term all-cause mortality based on Frailty Index (FI) among patients who underwent Cardiac Resynchronization Therapy (CRT) implantation.
Methods
We calculated patients' FI individually using 30 clinical parameters from our retrospective single centre large-scale registry. The applied clinical features incorporated patients' medical history, anthropometric-, laboratory and echocardiographic parameters. Based on previous studies, patients with FI ≤0.210 were classified as non-frail, and patients above that value were considered frail. Frail patients were divided into two different subgroups (F1; F2) by a FI increment of 0.100 based on the Rockwood method. Primary endpoint was all-cause mortality, log-rank and Cox multivariate analysis were performed.
Results
Among 1010 included patients, 58 (6%) were considered as Non-frail, while 245 (24%) and 707 (70%) participants were categorized to F1- and F2 groups. Patients in F2 group were older [non-frail 62 years (IQR 57–68) vs. F1 66 years (IQR 57–73) vs. F2 70 years (IQR 63–76); p<0.001], had worse laboratory parameters as higher creatinine, uric acid, lower sodium or hemoglobin levels (p<0.001) and more comorbidities than patients of Non-frail or F1 groups. During the median follow-up time of 4.4 (2.3–6.9) years, 17 (29%) patients in the Non-frail group, 103 (42%) in Frail group 1 and 479 (68%) in the Frail group 2 reached the primary endpoint. Non-frail patients showed the best outcome, and patients in the Frail group 1 demonstrated a 46% (HR 0.46, 95% CI 0.39–0.55; p<0.001) lower all-cause mortality risk compared to Frail group 2. In the total cohort, mortality predictors were also assessed, NYHA functional class, serum sodium, creatinine and TAPSE were identified as independent predictors of all-cause mortality.
Conclusion
By calculating individual frailty index among CRT patients, distinct groups could be identified, of which mortality differed significantly. Those with the highest Frailty index demonstrated the worse outcome compared to lower index or non-frail patients. Frailty index can help selecting the most vulnerable patients, requiring a strict follow-up.
Funding Acknowledgement
Type of funding sources: None.
Collapse
Affiliation(s)
- L Kuthi
- Semmelweis University Heart and Vascular Center , Budapest , Hungary
| | - W Schwertner
- Semmelweis University Heart and Vascular Center , Budapest , Hungary
| | - B Veres
- Semmelweis University Heart and Vascular Center , Budapest , Hungary
| | - E Merkel
- Semmelweis University Heart and Vascular Center , Budapest , Hungary
| | - A Behon
- Semmelweis University Heart and Vascular Center , Budapest , Hungary
| | - R Masszi
- Semmelweis University Heart and Vascular Center , Budapest , Hungary
| | - A Kovacs
- Semmelweis University Heart and Vascular Center , Budapest , Hungary
| | - I Osztheimer
- Semmelweis University Heart and Vascular Center , Budapest , Hungary
| | - L Molnar
- Semmelweis University Heart and Vascular Center , Budapest , Hungary
| | - E Zima
- Semmelweis University Heart and Vascular Center , Budapest , Hungary
| | - L Geller
- Semmelweis University Heart and Vascular Center , Budapest , Hungary
| | - A Kosztin
- Semmelweis University Heart and Vascular Center , Budapest , Hungary
| | - B Merkely
- Semmelweis University Heart and Vascular Center , Budapest , Hungary
| |
Collapse
|
14
|
Sallo Z, Perge P, Orban G, Piros K, Herczeg SZ, Nagy KV, Abraham P, Osztheimer I, Merkely B, Geller L, Szegedi N. Impact of high-power and very high-power short-duration radiofrequency ablation on procedure characteristics and first-pass isolation during pulmonary vein isolation. Eur Heart J 2022. [DOI: 10.1093/eurheartj/ehac544.576] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Abstract
Abstract
Introduction
High-power short-duration (HPSD) radiofrequency ablation has been proposed as a method for producing rapid and effective lesions for pulmonary vein isolation (PVI). We aimed to evaluate the procedural characteristics and the first-pass isolation (FPI) rate of HPSD and very high-power short-duration (vHPSD) ablation compared to low-power long-duration (LPLD) ablation technique.
Methods
156 patients with atrial fibrillation (AF) were enrolled and assigned to LPLD, HPSD, or vHPSD PVI. The energy setting was 30W, 50W, and 90W in the LPLD, HPSD, and vHPSD groups, respectively.
Results
Bilateral PVI was achieved in all cases. The procedure time was 85 [75–101] min, 79 [65–91] min, and 70 [53–83] min in the LPLD, HPSD, and vHPSD groups, respectively (p<0.0001). Left atrial (LA) dwelling times were also decreased significantly with the increase of RF energy (61 [55–70] min, 53 [41–56] min, and 45 [34–52] min, in the LPLD, HPSD, and vHPSD groups, respectively, p<0.0001). The total RF ablation time was 1567 [1366–1761] sec, 1398 [1021–1711] sec, and 336 [247–386] sec in the LPLD, HPSD, and vHPSD group, respectively (p<0.0001). The bilateral FPI rate was 57%, 78%, and 80% in the LPLD, HPSD, and vHPSD groups, respectively (p=0.0097). On the left side, FPI was achieved in 66% in the LPLD, 92% in the HPSD, and 85% in the vHPSD ablation group (p=0.0015). FPI on the right side was achieved in 72% in the LPLD, 88% in the HPSD, and 88% in the vHPSD ablation group (p=0.0188). The univariate analysis revealed that the use of HPSD (both sides: OR=2.72, 95% CI 1.15–6.44, p=0.023; right side: OR=2.90, 95% CI 1.02–8.20, p=0.045; left side: OR=5.91, 95% CI 1.84–19.04, p=0.003) and vHPSD (both sides: OR=2.90, 95% CI 1.24–6.44, p=0.014; right side: OR=3.09, 95% CI 1.09–8.74, p=0.045; left side: OR=2.89, 95% CI 1.13–7.43, p=0.027) ablation techniques were associated with a higher probability of FPI. The mid-term arrhythmia-free survival was similarly high in all three groups.
Conclusion
Our prospective, observational cohort study showed that both HPSD and vHPSD RF ablation is effective, as it shortens procedure time and RF time and results in a higher rate of FPI compared to LPLD ablation. Moreover, the mid-term arrhythmia-free survival was similarly high in all three groups. In our study, no safety concerns were raised for HPSD or vHPSD ablation.
Funding Acknowledgement
Type of funding sources: None.
Collapse
Affiliation(s)
- Z Sallo
- Semmelweis University Heart and Vascular Center , Budapest , Hungary
| | - P Perge
- Semmelweis University Heart and Vascular Center , Budapest , Hungary
| | - G Orban
- Semmelweis University Heart and Vascular Center , Budapest , Hungary
| | - K Piros
- Semmelweis University Heart and Vascular Center , Budapest , Hungary
| | - S Z Herczeg
- Semmelweis University Heart and Vascular Center , Budapest , Hungary
| | - K V Nagy
- Semmelweis University Heart and Vascular Center , Budapest , Hungary
| | - P Abraham
- Semmelweis University Heart and Vascular Center , Budapest , Hungary
| | - I Osztheimer
- Semmelweis University Heart and Vascular Center , Budapest , Hungary
| | - B Merkely
- Semmelweis University Heart and Vascular Center , Budapest , Hungary
| | - L Geller
- Semmelweis University Heart and Vascular Center , Budapest , Hungary
| | - N Szegedi
- Semmelweis University Heart and Vascular Center , Budapest , Hungary
| |
Collapse
|
15
|
Fabian A, Tolvaj M, Lakatos BK, Assabiny A, Ujvari A, Shiida K, Ferencz A, Schwertner W, Veres B, Kosztin A, Staub L, Sax B, Merkely B, Kovacs A. There is more than just longitudinal strain: prognostic significance of biventricular circumferential mechanics. Eur Heart J 2022. [DOI: 10.1093/eurheartj/ehac544.104] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Global longitudinal strain is a well-established predictive parameter of adverse outcomes in several cardiac diseases, therefore, it is widely used in clinical practice. Despite the significant contribution of circumferential shortening to the global ventricular function, data are scarce concerning the biventricular circumferential strain phenotypes and their prognostic value on long-term mortality.
Accordingly, the aim of our study was to assess both left (LV) and right ventricular (RV) global circumferential strain (GCS) using 3D echocardiography in order to determine the prognostic importance of the deterioration of biventricular circumferential mechanics.
Three hundred and sixty-four patients with various established left-sided heart diseases were retrospectively identified (age: 64.8±15.0 years, 69% males) with a median follow-up of 41 months. All patients underwent clinically indicated transthoracic echocardiography and left (LV) and right ventricular (RV) ejection fractions (EF) were measured by 3D analysis. 3D LV and RV GCS were also quantified by dedicated softwares. In order to determine the prognostic power of the different patterns of biventricular circumferential mechanics, we divided the patient population into four groups using the median values of LV and RV GCS (absolute values of 27.1% and 17.9%, respectively). Group 1 consisted of patients with both LV and RV GCS above median values; Group 2 was defined as patients with LV GCS above the median, while RV GCS below the median, whereas in Group 3 patients had LV GCS values below the median, while RV GCS was above median. Group 4 was defined as patients with both LV and RV GCS below the median. The primary endpoint of our study was all-cause mortality.
Fifty-five patients (15.1%) met the primary endpoint. The overall patient population showed balanced values of LV and RV EF (49.0±15.7 and 48.2±9.4%, respectively). Comparing the population separated into the above-mentioned four groups based on LV and RV GCS values enabled a detailed risk stratification as shown on the Kaplan-Meier curve (Figure 1.) When comparing Group 1 vs. Group 4, patients who had lower LV and RV GCS values the risk of all-cause mortality was more than 5 times higher than in patients with both LV and RV GCS above the median (HR, 5.240 [95% CI, 2.750–9.985], p<0.001). By comparing Group 2 with Group 3, the associated risks for all-cause mortality did not show a difference (HR, 0.461 [95% CI, 0.178 to 1.194], p=NS) as shown on the Kapan-Meier curve (Figure 2).
Based on the different phenotypes of LV and RV GCS, decreased biventricular circumferential shortening was associated with a significantly increased risk of long-term all-cause mortality. Interestingly, decreased RV GCS with maintained LV GCS showed a similar risk of adverse outcomes than decreased LV GCS with maintained RV GCS. Our results emphasize the importance of the assessment of biventricular circumferential mechanics.
Funding Acknowledgement
Type of funding sources: None.
Collapse
Affiliation(s)
- A Fabian
- Semmelweis University, Heart and Vascular Center , Budapest , Hungary
| | - M Tolvaj
- Semmelweis University, Heart and Vascular Center , Budapest , Hungary
| | - B K Lakatos
- Semmelweis University, Heart and Vascular Center , Budapest , Hungary
| | - A Assabiny
- Semmelweis University, Heart and Vascular Center , Budapest , Hungary
| | - A Ujvari
- Semmelweis University, Heart and Vascular Center , Budapest , Hungary
| | - K Shiida
- Semmelweis University, Heart and Vascular Center , Budapest , Hungary
| | - A Ferencz
- Semmelweis University, Heart and Vascular Center , Budapest , Hungary
| | - W Schwertner
- Semmelweis University, Heart and Vascular Center , Budapest , Hungary
| | - B Veres
- Semmelweis University, Heart and Vascular Center , Budapest , Hungary
| | - A Kosztin
- Semmelweis University, Heart and Vascular Center , Budapest , Hungary
| | - L Staub
- Argus Cognitive , Lebanon , United States of America
| | - B Sax
- Semmelweis University, Heart and Vascular Center , Budapest , Hungary
| | - B Merkely
- Semmelweis University, Heart and Vascular Center , Budapest , Hungary
| | - A Kovacs
- Semmelweis University, Heart and Vascular Center , Budapest , Hungary
| |
Collapse
|
16
|
Babity M, Zamodics M, Kovacs E, Konig A, Rakoczi R, Horvath M, Kiss A, Herczeg SZ, Varga A, Fabian A, Lakatos BK, Vago H, Kovacs A, Merkely B, Kiss O. Extension of fitness evaluations with muscle oxygen saturation measurements based on near-infrared spectroscopy analysis during cardiopulmonary exercise testing in elite athletes. Eur Heart J 2022. [DOI: 10.1093/eurheartj/ehac544.2466] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Introduction
Many cardiovascular parameters of sport adaptation have become an area of detailed research in recent decades. However, details of local circulatory and metabolic processes ongoing in the working muscles during physical exercise need to be revealed.
Purpose
Our aim was to extend cardiopulmonary exercise testing with near-infrared spectroscopy measurements to focus on observing local changes in the contracting muscles during running.
Methods
Mixed muscle oxygen saturation values (SmO2) measured in the left vastus lateralis muscle of athletes were analyzed by near-infrared spectroscopy during vita maxima treadmill cardiopulmonary exercise testing with 2-min fingertip lactate measurements. Body composition analysis was carried out with bioimpedance method. One-way repeated measures ANOVA, Tukey post-hoc test, Shapiro–Wilk test and Pearson correlation were used for statistical analysis.
Results
The results of 66 elite athletes (male: 40; age: 17.9±3.6 y; training: 17.7±6.6 h/w; water polo player: 56, wrestler: 8, basketball player: 2) were analyzed. The 10-second averaged values of the measured saturation values were examined at rest (65.8±11.1%), at the anaerobic threshold (40.7±22.8%), at maximum load (30.2±20.5%) and after 5 minutes of cool-down (70.9±12.8%). Significant differences were measured between the four measurement time points in all pairings. A negative correlation was found between the achieved maximal oxygen uptake and the muscle oxygen saturation values measured at the anaerobic threshold and at the maximal load (respectively r=−0.30, p<0.02; r=−0.32, p<0.01). Oxygen uptake at the end of cool-down was also negatively correlated with muscle oxygen saturation values measured at the anaerobic threshold and at the peak of exercise (respectively r=−0.27, p<0.05; r=−0.27, p<0.05). The fat-free mass of the identical limb showed negative correlation with the muscle oxygen saturation values measured at the anaerobic threshold, at the maximal load and at the cool-down (respectively r=−0.43, p<0.01; r=−0.44, p<0.01; r=−0.35, p<0.01), while positive interactions were observed between the body-fat mass of the same limb and the muscle oxygen saturation values (respectively r=0.51, p<0.01; r=0.55, p<0.01; r=0.41, p<0.01). Muscle oxygen saturation values showed no significant correlations with exercise time, lactate levels, or heart rate measurements.
Conclusions
By our results, muscle oxygen saturation measurements can be reliably applied during exercise physiological measurements. During exercise, muscle oxygen saturation values negatively correlated with oxygen uptake. At the cool-down phase, a rebound effect could be observed compared to the resting measurements. On the identical limb, the higher the muscle mass was, the higher muscle desaturation could be measured. This easy-to-perform test provides insight into muscle metabolism processes and can help with training planning and athlete follow-up.
Funding Acknowledgement
Type of funding sources: Public grant(s) – National budget only. Main funding source(s): This project was supported by a grant from the National Research, Development and Innovation Office (NKFIH) of Hungary (K 135076). Supported by the ÚNKP-21-3-I-SE-68 New National Excellence Program of the Ministry for Innovation and Technology from the Source of the National Research, Development and Innovation fund.
Collapse
Affiliation(s)
- M Babity
- Semmelweis University Heart and Vascular Center , Budapest , Hungary
| | - M Zamodics
- Semmelweis University Heart and Vascular Center , Budapest , Hungary
| | - E Kovacs
- Semmelweis University Heart and Vascular Center , Budapest , Hungary
| | - A Konig
- Semmelweis University Heart and Vascular Center , Budapest , Hungary
| | - R Rakoczi
- Semmelweis University Heart and Vascular Center , Budapest , Hungary
| | - M Horvath
- Semmelweis University Heart and Vascular Center , Budapest , Hungary
| | - A Kiss
- Semmelweis University Heart and Vascular Center , Budapest , Hungary
| | - S Z Herczeg
- Semmelweis University Heart and Vascular Center , Budapest , Hungary
| | - A Varga
- Semmelweis University Heart and Vascular Center , Budapest , Hungary
| | - A Fabian
- Semmelweis University Heart and Vascular Center , Budapest , Hungary
| | - B K Lakatos
- Semmelweis University Heart and Vascular Center , Budapest , Hungary
| | - H Vago
- Semmelweis University Heart and Vascular Center , Budapest , Hungary
| | - A Kovacs
- Semmelweis University Heart and Vascular Center , Budapest , Hungary
| | - B Merkely
- Semmelweis University Heart and Vascular Center , Budapest , Hungary
| | - O Kiss
- Semmelweis University Heart and Vascular Center , Budapest , Hungary
| |
Collapse
|
17
|
Vamosi P, Kegyes-Brassai AC, Toth P, Komlosi F, Kulyassa PM, Engh MA, Fehervari P, Merkely B, Geller L, Nagy KV. Major vascular complications are reduced by ultrasound guided venous puncture compared to conventional technique in cardiac catheter ablation: a meta-analysis. Eur Heart J 2022. [DOI: 10.1093/eurheartj/ehac544.477] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Background
Puncture site vascular complications are relatively common during invasive electrophysiology. One of the most promising measures to minimize these adverse events is the use of vascular ultrasound during puncture.
Objective
We aimed to carry out a meta-analysis comparing conventional, anatomically guided femoral venous puncture to ultrasound-guided puncture during electrophysiology procedures, which, in contrast to, the previous meta-analyses, used a uniform endpoint and involved novel trials resulting in higher patients numbers.
Methods
We conducted a systematic search in relevant electronic databases for articles reporting the rate of vascular complications during EP procedures both with and without ultrasound guidance. We defined major vascular complications (MVCs, as defined in the 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus) as the primary endpoint. Secondary endpoints were arteriovenous fistula, pseudoanerurysm and major bleeding separately, and minor vascular complications and accidental arterial punctures. Statistical analysis was performed using a random effect model with the Mantel-Haenszel method.
Results
A total of 23605 patients were included in the 14 articles matching our selection criteria, and there were data on the primary outcome in 15160 of them (in 11 articles), with 236 (1.6%), who reached the primary endpoint of an MVC. Routine application of ultrasound guidance significantly reduced the incidence of major vascular complications (42/5645 vs. 194/9515, OR 0.36 [0.23–0.55], p<0.001). Furthermore, we found significantly lower incidence in several of our secondary endpoints: for total vascular complications the OR was 0.27 [0.13–0.53] (p<0.001), for major bleedings the OR was 0.42 [0.24–0.74] and for inadvertent artery puncture the OR was 0.24 [0.15–0.38] (p<0.001). Data was insufficiently reported in respect of arteriovenous fistulae and of pseudoanerurysms specifically.
Conclusion
With more than double of the number of patients compared to the previous meta-analyses, and with a more consistent MVC definition, we showed that ultrasound guidance for femoral venous puncture has significant benefits, most importantly reduces the incidence of major vascular complications and total vascular complications.
Our results underscore the need for a randomized controlled trial in the question, with potentially important implications for daily clinical practice and patient safety.
Funding Acknowledgement
Type of funding sources: Public grant(s) – National budget only. Main funding source(s): Project no. NVKP_16-1–2016-0017 (“National Heart Program”) has been implemented with the support provided by the Ministry of Innovation and Technology of Hungary from the National Research, Development and Innovation Fund of Hungary, financed under the NVKP_16 funding scheme. -Project no. MEC_R-141548 has been implemented with the support provided by the Ministry of Innovation and Technology of Hungary from the National Research, Development and Innovation Fund, financed under the MEC_R_21 funding scheme.
Collapse
Affiliation(s)
- P Vamosi
- Semmelweis University, Heart and Vascular Center , Budapest , Hungary
| | | | - P Toth
- Semmelweis University, Heart and Vascular Center , Budapest , Hungary
| | - F Komlosi
- Semmelweis University, Heart and Vascular Center , Budapest , Hungary
| | - P M Kulyassa
- Semmelweis University, Heart and Vascular Center , Budapest , Hungary
| | - M A Engh
- Semmelweis University, Center for Translational Medicine , Budapest , Hungary
| | - P Fehervari
- Semmelweis University, Center for Translational Medicine , Budapest , Hungary
| | - B Merkely
- Semmelweis University, Heart and Vascular Center , Budapest , Hungary
| | - L Geller
- Semmelweis University, Heart and Vascular Center , Budapest , Hungary
| | - K V Nagy
- Semmelweis University, Heart and Vascular Center , Budapest , Hungary
| |
Collapse
|
18
|
Lakatos BK, Ruppert M, Ladanyi Z, Fabian A, Ujvari A, Turschl T, Molnar B, Straub E, Molnar A, Nagy A, Molnar L, Kovacs A, Merkely B. Clinical determinants of non-invasive global myocardial work index before and after transcatheter aortic valve implantation: a prospective study. Eur Heart J 2022. [DOI: 10.1093/eurheartj/ehac544.1551] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
The estimation of non-invasive global myocardial work indices is a novel method of the left ventricular (LV) functional assessment, which may overcome the load-sensitvity of the traditional functional measures. The diagnostic and prognostic role of this approach may gain particular importance in pressure overload states, such as in patients with severe aortic stenosis. However, the longitudinal changes of this recently introduced measure are scarcely investigated, and data are also lacking about the main determinants of these measures.
Accordingly, our aim was to investigate the clinical determinants of preoperative and also postoperative GMWI in patients undergoing transcatheter aortic valve replacement (TAVR).
Fifty patients (62% male, age: 78±5 years) were enrolled. Prior to the procedure, subjects underwent echocardiographic investigation and the detailed medical history was also recorded. Speckle-tracking analysis was performed and global longitudinal strain (GLS) was measured. LV pressure curve was estimated by adding the mean aortic valve gradient to the systolic blood pressure. Using these measures, global myocardial work index (GMWI) and global constructive work index (CMWI) was quantified by commercially available software. A 6 months follow-up examination was also performed and at that time point we determined the aforementioned parameters.
At follow-up, GLS has significantly increased (−13.0±4.1 vs. −14.8±3.8%; p<0.001), while GMWI was significantly lower compared to baseline (1789±748 vs. 1506±561 mmHg%, p<0.01). CMWI did not differ between the two time points (2309±782 vs. 2086±609 mmHg%, p=0.11). Using multivariable analysis, age (β=0.30; p<0.05) preoperative New York Heart Association (NYHA) class (β=−0.48; p<0.001) and having a pacemaker (β=−0.44; p<0.01) were found to be independent predictors of the preoperative GMWI (R2=0.39; overall p<0.001). On the other hand, postoperative GMWI was determined (R2=0.48; overall p<0.001) by gender (β=−0.25; p<0.05), the presence of diabetes mellitus (β=−0.37; p<0.01) and also by having a pacemaker (β=−0.38; p<0.01).
TAVR significantly alters LV functional measures. Different clinical factors influence GMWI before and after the procedure: age, NYHA class-based symptom severity and having a pacemaker were found to be independently associated with preoperative GMWI, while gender, the presence of diabetes mellitus and pacemaker device are the most important clinical determinants of the postoperative GMWI value.
Funding Acknowledgement
Type of funding sources: None.
Collapse
Affiliation(s)
- B K Lakatos
- Semmelweis University Heart and Vascular Center , Budapest , Hungary
| | - M Ruppert
- Semmelweis University Heart and Vascular Center , Budapest , Hungary
| | - Z Ladanyi
- Semmelweis University Heart and Vascular Center , Budapest , Hungary
| | - A Fabian
- Semmelweis University Heart and Vascular Center , Budapest , Hungary
| | - A Ujvari
- Semmelweis University Heart and Vascular Center , Budapest , Hungary
| | - T Turschl
- Semmelweis University Heart and Vascular Center , Budapest , Hungary
| | - B Molnar
- Semmelweis University Heart and Vascular Center , Budapest , Hungary
| | - E Straub
- Semmelweis University Heart and Vascular Center , Budapest , Hungary
| | - A Molnar
- Semmelweis University Heart and Vascular Center , Budapest , Hungary
| | - A Nagy
- Semmelweis University Heart and Vascular Center , Budapest , Hungary
| | - L Molnar
- Semmelweis University Heart and Vascular Center , Budapest , Hungary
| | - A Kovacs
- Semmelweis University Heart and Vascular Center , Budapest , Hungary
| | - B Merkely
- Semmelweis University Heart and Vascular Center , Budapest , Hungary
| |
Collapse
|
19
|
Ladanyi Z, Lakatos BK, Ruppert M, Fabian A, Ujvari A, Molnar B, Turschl T, Fejer C, Apor A, Nagy AI, Molnar L, Kovacs A, Merkely B. Right ventricular mechanics and its association with symptoms in transcatheter aortic valve replacement candidates: a three-dimensional echocardiography study. Eur Heart J 2022. [DOI: 10.1093/eurheartj/ehac544.1798] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Abstract
Abstract
Aortic valve stenosis is one of the most prevalent valvular disease with significant clinical burden. While it is initially a disorder of the left ventricle (LV), long-term effects of the disease also affect the right ventricle (RV) as well. Nevertheless, data are scarce regarding the changes of RV mechanics and their association with symptomatic status of the patients. 3D echocardiography allows a more detailed assessment of the RV, which may unveil distinct changes of its morphology and function in this clinical setting.
Accordingly, our aim was to examine LV and RV mechanics in TAVR candidate patients with severe aortic stenosis using three-dimensional (3D) echocardiography.
Seventy patients (51% male, age: 80±6 years) were enrolled. Detailed medical history and symptomatic status were obtained. Beyond conventional transthoracic echocardiographic protocol, 3D loops were also acquired. We measured 3D LV and RV end-diastolic volume indexed to body surface area (EDVi), ejection fraction (EF) and global longitudinal (GLS) using dedicated software. Furthermore, we have determined 3D RV global longitudinal (RV GLS) and circumferential strain (RV GCS) using the ReVISION method.
LV EF (r=0.28, p<0.05) and LV GLS (r=−0.26, p<0.05) significantly correlated with age, while RV EF (r=0.21, p=0.11), RV GLS (r=−0.17, p=0.19) and RV GCS (r=−0.07, p=0.61) did not show association with it. 41% (n=29) of the patient population mentioned angina or had syncope. Patients with these symptoms had comparable LV EDVi (73±23 vs. 69±25 mL/m2, p=0.47), LV EF (47±15 vs. 51±10%, p=0.14) and LV GLS (−13.6±4.8 vs. −14.8±2.6%, p=0.25) to those who did not mention these complaints. On the other hand, patients with angina or syncope in their medical history had significantly lower RV EDVi (58±13 vs. 70±23 mL/m2, p<0.05), while having significantly higher RV EF (46±10 vs. 52±7%, p<0.05). Moreover, symptomatic patients had significantly lower RV GCS (−15.7±5.6 vs. −19.6±5.3%, p<0.01), while RV GLS did not differ (−15.8±4.8 vs. −17.4±4.1%, p=0.17).
Patients with severe aortic stenosis have marked changes in not only the LV, but the RV mechanics as well. While the symptomatic status does not seem to be associated with LV morphology and function, patients with angina or syncope had distinct changes in RV size and the contraction pattern of the chamber.
Funding Acknowledgement
Type of funding sources: None.
Collapse
Affiliation(s)
- Z Ladanyi
- Semmelweis University Heart and Vascular Center , Budapest , Hungary
| | - B K Lakatos
- Semmelweis University Heart and Vascular Center , Budapest , Hungary
| | - M Ruppert
- Semmelweis University Heart and Vascular Center , Budapest , Hungary
| | - A Fabian
- Semmelweis University Heart and Vascular Center , Budapest , Hungary
| | - A Ujvari
- Semmelweis University Heart and Vascular Center , Budapest , Hungary
| | - B Molnar
- Semmelweis University Heart and Vascular Center , Budapest , Hungary
| | - T Turschl
- Semmelweis University Heart and Vascular Center , Budapest , Hungary
| | - C Fejer
- Semmelweis University Heart and Vascular Center , Budapest , Hungary
| | - A Apor
- Semmelweis University Heart and Vascular Center , Budapest , Hungary
| | - A I Nagy
- Semmelweis University Heart and Vascular Center , Budapest , Hungary
| | - L Molnar
- Semmelweis University Heart and Vascular Center , Budapest , Hungary
| | - A Kovacs
- Semmelweis University Heart and Vascular Center , Budapest , Hungary
| | - B Merkely
- Semmelweis University Heart and Vascular Center , Budapest , Hungary
| |
Collapse
|
20
|
Nagy AI, Bartykowszki A, Apor A, Suhai F, Varga A, Manouras A, Szilveszter B, Panajotu A, Jermendy A, Turani M, Molnar L, Papp R, Merkely B, Maurovich-Horvat P. Hypoattenuated leaflet thickening is associated with silent brain injury. Eur Heart J 2022. [DOI: 10.1093/eurheartj/ehac544.1613] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Background
The association between hypoattenuated leaflet thickening (HALT) following transcatheter aortic valve implantation (TAVI) and stroke remains contradictory. Whether HALT carries an increased risk of subclinical brain injury (SBI) has not been investigated.
Purpose
We investigated whether HALT is associated with SBI on MRI. Furthermore, we assessed whether post-TAVR SBI impacts the patients' cognition and outcome.
Methods
153 patients undergoing TAVR were prospectively enrolled. Brain MRI was performed shortly post-TAVR and 6 months (6M) later to assess the occurrence of acute silent cerebral ischaemic lesions (SCIL) and chronic white matter hyperintensities (WMH). HALT was screened by cardiac CT angiography 6M post-TAVR. Neurocognitive evaluation was performed before, shortly after and 6M following TAVR.
Results
At 6M, 115 patients had diagnostic CTA and 10 had HALT. HALT status, baseline and follow-up MRIs were available in 91 cases. At 6M, new SCIL was evident in 16%, new WMH in 66%. New WMH was more frequent (100% vs 62%; p=0.047) with higher median volume (319 vs 50 mm3; p=0.039) among HALT-patients. In uni- and multivariate analysis, HALT was associated with new WMH volume (beta: 0.72; 95% CI: 0.2–1.39; p=0.009).
The patients' cognitive trajectory from pre-TAVR to 6M showed significant association with the 6M SCIL volume (beta: −4.69; 95% CI: −9.13 to −027; p=0.038), but was not related to the presence or volume of new WMH. During a 3.1-year follow-up neither HALT, nor the related WMH burden was related with increased mortality (HALT HR: 0.86, 95% CI: 0,202–3,687; p=0.84; new WMH HR: 1.09; 95% CI: 0,701–1,680; p=0.71).
Conclusions
6M post-TAVR, HALT was linked with greater WMH burden, but did not carry an increased risk of cognitive decline or mortality over a 3.1-year follow-up.
Funding Acknowledgement
Type of funding sources: Public Institution(s). Main funding source(s): János Bolyai Scholarship of the Hungarian Academy of Sciences
Collapse
Affiliation(s)
- A I Nagy
- Semmelweis University, Heart Center , Budapest , Hungary
| | - A Bartykowszki
- Semmelweis University, Heart Center , Budapest , Hungary
| | - A Apor
- Semmelweis University, Heart Center , Budapest , Hungary
| | - F Suhai
- Semmelweis University, Heart Center , Budapest , Hungary
| | - A Varga
- Semmelweis University, Heart Center , Budapest , Hungary
| | - A Manouras
- Karolinska Institute, Huddinge University Hospital, Department of Cardiology , Stockholm , Sweden
| | - B Szilveszter
- Semmelweis University, Heart Center , Budapest , Hungary
| | - A Panajotu
- Semmelweis University, Heart Center , Budapest , Hungary
| | - A Jermendy
- Semmelweis University, Heart Center , Budapest , Hungary
| | - M Turani
- Medical Centre, Hungarian Defence Forces, Cardiology , Budapest , Hungary
| | - L Molnar
- Semmelweis University, Heart Center , Budapest , Hungary
| | - R Papp
- Semmelweis University, Heart Center , Budapest , Hungary
| | - B Merkely
- Semmelweis University, Heart Center , Budapest , Hungary
| | | |
Collapse
|
21
|
Sayour AA, Olah A, Ruppert M, Barta BA, Benke K, Merkely B, Radovits T. Pharmacological selectivity of SGLT2 inhibitors and cardiovascular outcomes in patients with type 2 diabetes: a meta-analysis. Eur Heart J 2022. [DOI: 10.1093/eurheartj/ehac544.2688] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Abstract
Abstract
Background
Sodium-glucose cotransporter 2 (SGLT2) inhibitors reduce major adverse cardiovascular events (MACE) in patients with type 2 diabetes mellitus. However, SGLT2 inhibitors show great variance in pharmacological selectivity to SGLT2 over SGLT1. Reduced functional capacity of SGLT1 is associated with lower risk of heart failure development and mortality in humans. Yet, the clinical relevance of additional pharmacological SGLT1 inhibition is unclear.
Purpose
To assess whether additional pharmacological SGLT1 blockade adds further benefits to SGLT2 inhibition.
Methods
In this preregistered meta-analysis, we included randomized placebo-controlled cardiovascular outcome trials (CVOTs) of SGLT2 inhibitors assessing MACE (composite of cardiovascular death, nonfatal myocardial infarction, and nonfatal stroke) in patients with type 2 diabetes. Hazard ratios (HRs) and 95% confidence intervals (CIs) of prespecified clinical endpoints were pooled using a random-effects model. Interactions were assessed according to low versus high pharmacological SGLT2 selectivity of the given medication. Mixed-effects meta-regression analysis was performed to quantify correlation between pharmacological SGLT2:SGLT1 selectivity ratio and clinical outcomes.
Results
A total of 6 independent CVOTs comprising 57553 type 2 diabetic patients (mean age 64.6±7.9 years; 36769 [63.9%] men) were included. Overall, SGLT2 inhibitors significantly reduced risk of adverse cardiovascular and renal outcomes, but had no significant impact on the risk of fatal and nonfatal stroke compared with placebo (HR, 0.92; 95% CI, 0.77–1.10; p=0.36; I2=63%). Agents with clinically relevant SGLT1 inhibitory effect (sotagliflozin, canagliflozin) significantly reduced the risk of stroke (HR, 0.78; 95% CI, 0.64–0.94) compared with placebo, whereas those with high SGLT2 selectivity did not (HR, 1.06; 95% CI, 0.92–1.22), yielding a significant interaction (p=0.018). The difference was also significant in patients with estimated glomerular filtration rate (eGFR) lower than 60 mL/min/1.73 m2 (p=0.047). Meta-regression indicated that lower SGLT2:SGLT1 pharmacological selectivity ratio was associated with lower risk of stroke (pseudo-R2=78%; p=0.011), which was evident even after adjusting for baseline eGFR values (p=0.047). Pharmacological selectivity of SGLT2 inhibitors had no significant impact on any other assessed clinical outcomes, including hospitalization for heart failure and all-cause death.
Conclusion
These hypothesis-generating results indicate that targeting SGLT1 in addition to SGLT2 inhibition might constitute a new avenue for stroke risk reduction in patients with type 2 diabetes. Further confirmatory studies are needed.
Funding Acknowledgement
Type of funding sources: Public grant(s) – National budget only. Main funding source(s): This project was supported by grants from the National Research, Development and Innovation Office (NKFIH) of Hungary (K134939 to T.R.), and by the New National Excellence Program of the Ministry of Human Capacities of Hungary (ÚNKP-21-3-II-SE-45 to A.A.S.).
Collapse
Affiliation(s)
- A A Sayour
- Semmelweis University Heart and Vascular Center , Budapest , Hungary
| | - A Olah
- Semmelweis University Heart and Vascular Center , Budapest , Hungary
| | - M Ruppert
- Semmelweis University Heart and Vascular Center , Budapest , Hungary
| | - B A Barta
- Semmelweis University Heart and Vascular Center , Budapest , Hungary
| | - K Benke
- Semmelweis University Heart and Vascular Center , Budapest , Hungary
| | - B Merkely
- Semmelweis University Heart and Vascular Center , Budapest , Hungary
| | - T Radovits
- Semmelweis University Heart and Vascular Center , Budapest , Hungary
| |
Collapse
|
22
|
Veres B, Gharehdaghi S, Engh M, Schwertner W, Kuthi L, Merkel ED, Masszi R, Fehervari P, Behon A, Osztheimer I, Hegyi P, Kovacs A, Zima E, Kosztin A, Merkely B. The benefits of adding a defibrillator to cardiac resynchronization therapy – systematic review and meta-analysis. Eur Heart J 2022. [DOI: 10.1093/eurheartj/ehac544.735] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Abstract
Abstract
Background
There is an long-standing debate whether cardiac resynchronisation therapy-defibrillation (CRT-D) is preferred over CRT-pacemaker (CRT-P). No randomised controlled trials have been designed to compare these treatments. However, several observational studies have been performed so far providing controversial results.
Methods
PubMed, CENTRAL and Embase until October 2021 were screened for studies comparing CRT-P and CRT-D, focusing on all-cause mortality, cardiovascular mortality, sudden cardiac death, and non-cardiac death. Conference abstracts were excluded. Odds ratio with 95% confidence interval (CI) was calculated, data from the selected studies were pooled using a random effect model (Mantel-Haenszel method, where more than 5 studies with Hartung-Knapp adjustment). τ2 was estimated by Paule-Mandel method with CI calculated by Q profile method. Statistical heterogeneity was assessed by Cochrane Q test and I2 test. Results were summarized by Forest and drapery plots.
Results
Altogether 20 observational retrospective studies (69,124 patients) were included (CRT-P: 37,461, CRT-D: 31,663). CRT-D was superior to CRT-P regarding all-cause mortality in multivariate analysis (aHR: 0.79; 95% CI: 0.69–0.88; p<0.01). Based on propensity matched studies (25,040 patients; 12,520 CRT-P, 12,520 CRT-D) CRT-D showed significantly better survival compared to CRT-P (HR: 0.83; 95% CI: 0.79–0.87; p<0.001). Three studies (47,846 patients, CRT-P: 27,344, CRT-D: 20,502) compared cardiovascular mortality between CRT-D and CRT-P. Univariate analysis showed a significantly lower rate of cardiovascular mortality in patients implanted with a CRT-D device compared to patients with a CRT-P device (HR: 0.61; 95% CI: 0.50–0.73; p=0.002). Three studies (4,623 patients. CRT-P: 2,518, CRT-D: 2,105) reported on heart failure death, where CRT-D was associated with decreased heart failure mortality compared to CRT-P (HR: 0.68; 95% CI: 0.41–0.95; p=0.008). Five studies (6,434 patients. CRT-P: 3,475, CRT-D: 2,959) were analyzed for sudden cardiac death, CRT-D was superior in univariate analysis (HR: 0.33; 95% CI: 0.28–0.89; p=0.03). Three studies (48,770 patients, CRT-P: 28,398, CRT-D: 20,372) reported on non-cardiac death, CRT-D showed significantly better survival than CRT-P (HR: 0.58; 95% CI: 0.55–0.60; p<0.001).
Conclusion
Our meta-analysis demonstrated that patients with CRT-D had a lower risk of all-cause mortality compared to CRT-P based on those studies that used multivariate analysis and propensity score matching. Univariate analysis showed a significantly lower rate of cardiovascular heart failure mortality, sudden cardiac death, and non-cardiac death in patients implanted with a CRT-D device compared to patients with a CRT-P. However, due to the heterogeneity of the articles coming from the selection bias of patients for CRT-D/CRT-P implantation, this question requires further analysis.
Funding Acknowledgement
Type of funding sources: Other. Main funding source(s): The research presented here, carried out by Semmelweis University was supported by Semmelweis 250+ Excellence Scholarship (EFOP-3.6.3-VEKOP-16-2017-00009)as well as the Centre for Translational Medicine, Semmelweis University. This work was financed by the Thematic Excellence Programme (2020-4.1.1.-TKP2020) of the Ministry for Innovation and Technology in Hungary, within the framework of the Therapeutic Development and Bioimaging thematic programmes of the Semmelweis University. - I agree that this information can be anonymised and then used for statistical purposes only
Collapse
Affiliation(s)
- B Veres
- Semmelweis University , Budapest , Hungary
| | - S Gharehdaghi
- Semmelweis University, Translational Medicine , Budapest , Hungary
| | - M Engh
- Semmelweis University, Translational Medicine , Budapest , Hungary
| | | | - L Kuthi
- Semmelweis University , Budapest , Hungary
| | - E D Merkel
- Semmelweis University , Budapest , Hungary
| | - R Masszi
- Semmelweis University , Budapest , Hungary
| | - P Fehervari
- Semmelweis University, Translational Medicine , Budapest , Hungary
| | - A Behon
- Semmelweis University , Budapest , Hungary
| | | | - P Hegyi
- Semmelweis University, Translational Medicine , Budapest , Hungary
| | - A Kovacs
- Semmelweis University , Budapest , Hungary
| | - E Zima
- Semmelweis University , Budapest , Hungary
| | - A Kosztin
- Semmelweis University , Budapest , Hungary
| | - B Merkely
- Semmelweis University , Budapest , Hungary
| |
Collapse
|
23
|
Barta BA, Olah A, Bottlik O, Ruppert M, Sayour AA, Merkely B, Schilling O, Radovits T. Sex-related proteomic differences of the athlete's heart. Cardiovasc Res 2022. [DOI: 10.1093/cvr/cvac066.040] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Abstract
Abstract
Funding Acknowledgements
Type of funding sources: Public grant(s) – National budget only. Main funding source(s): Bolyai János Research Scholarship - BO/00837/21 to O.A., National Research, Development and Innovation Office (NKFIH) of Hungary - K135076 to B.M.
Introduction
Regular physical activity results in characteristic structural and functional changes in the heart, which are collectively referred to as the athlete’s heart. However, the extent of exercise-induced left ventricular (LV) hypertrophy and functional changes show significant differences between men and women, the molecular background of which is not fully elucidated.
Purpose
The aim of this study was to provide a proteomic characterization of long-term, intense exercise-induced LV myocardial hypertrophy in a rat model, with a focus on sex-related differences.
Methods
Our rats were divided into trained (FEx) and control female (FCo) as well as trained (MEx) and control male (MCo) groups. In the trained groups, athlete’s heart was induced by a 12-week swimming protocol. Myocardial hypertrophy was confirmed by echocardiography and functional adaptation by pressure-volume analysis. Proteomic measurements based on liquid chromatograph-coupled mass spectrometry were performed on proteins isolated from our LV myocardial samples.
Results
Echocardiography and post-mortem myocardial mass showed significant LV hypertrophy in both sexes, which was more pronounced in female animals (tibial length normalized LV muscle mass: + 17.4% MEx vs. MCo, + 31.0% FEx vs. FCo). LV contractility increased to the same extent in both sexes. Relative expression of 3074 proteins were determined by proteomics. There was a significant change in expression of 229 proteins in males and 599 in females compared to the level of same-sex controls. Based on our gene ontological analysis, physiological LV remodeling in females is characterized by increased expression of proteins in cellular respiration and fatty acid oxidation, whereas in males, proteins that bind to the actin cytoskeleton is primarily increased.
Conclusions
Our data suggests that physiological LV hypertrophy resulting from regular, balanced exercise is associated with sex-specific changes in the myocardial proteome. Our results contribute to the understanding of the development of physiological myocardial hypertrophy.
Collapse
Affiliation(s)
- BA Barta
- Semmelweis University, Heart and Vascular Center , Budapest , Hungary
| | - A Olah
- Semmelweis University, Heart and Vascular Center , Budapest , Hungary
| | - O Bottlik
- Semmelweis University, Heart and Vascular Center , Budapest , Hungary
| | - M Ruppert
- Semmelweis University, Heart and Vascular Center , Budapest , Hungary
| | - AA Sayour
- Semmelweis University, Heart and Vascular Center , Budapest , Hungary
| | - B Merkely
- Semmelweis University, Heart and Vascular Center , Budapest , Hungary
| | - O Schilling
- University Hospital of Freiburg, Institute of Surgical Pathology , Freiburg , Germany
| | - T Radovits
- Semmelweis University, Heart and Vascular Center , Budapest , Hungary
| |
Collapse
|
24
|
Barallobre-Barreiro J, Radovits T, Fava M, Daroczi L, Hasman M, Schmidt L, Baig F, Theofilatos K, Crespo-Leiro MG, Domenech N, Merkely B, Mayr M. Proteomics to assess myocardial remodelling in human heart failure and explore the effect of medications and comorbidities. Cardiovasc Res 2022. [DOI: 10.1093/cvr/cvac066.133] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Funding Acknowledgements
Type of funding sources: Foundation. Main funding source(s): British Heart Foundation
Background
Myocardial remodelling is a hallmark of heart failure (HF). Our previous proteomics analyses demonstrated a profound effect of beta blockers on cardiac extracellular matrix composition in ischaemic HF patients (1). No comprehensive proteomics characterizations has been performed in non-ischaemic HF patients.
Methods
Mass spectrometry was used to analyze intracellular and extracellular protein extracts from left ventricular samples obtained from patients with ischemic (n=65) and non-ischaemic (n=114) HF after heart transplantation, as well as non-failing controls (n=19). All HF patients had ventricular dilatation and reduced ejection fraction (EF%).
Results
The proteomics comparison across 198 cardiac samples with two tissue extracts revealed hallmarks of HF in both groups of patients compared to controls, including elevated levels of atrial natriuretric peptides and the fibroblast marker vimentin, as well as decreases in creatine kinase M/B, troponin C, and myosin light chain 2 (Figure 1). In comparison to ischaemic HF patients, non-ischaemic HF patients showed elevated levels of proteins involved in proteasome activation, consistent with the notion of increased protein degradation in cardiomyocytes even at the end stage of the disease (2). Despite similar clinical characteristics, myocardial remodelling in response to HF medications and the presence of comorbidities was different between the two HF groups. In ischaemic HF patients the use of β-blockers resulted in reduced proteoglycan deposition. In non-ischaemic patients, few protein changes were associated with medication. Instead, comorbidities such as atrial fibrillation and hypertension were critical determinants of myocardial protein remodelling in these HF patients (Figure 2). Notably, hypertensive HF patients showed a marked reduction in angiotensin converting enzyme 2 (ACE2) compared to normotensive patients, and this was accompanied by a reduction in Cysteine And Glycine Rich Protein 3 (CSRP3), a key player in the organization of cytosolic structures in cardiomyocytes, and the nuclear lamina proteins lamin A/C and B. The inflammation-related galectin 3-binding protein was reduced in hypertensive patients as were the extracellular proteases matrix metalloprotease 2, cathepsin G and chymase 1.
Conclusion
Our study constitutes the largest proteomics analysis of HF to date. We observed distinct protein remodelling processes in ischaemic and non-ischaemic HF patients and discerned the myocardial effects of medications and comorbidities such as hypertension.
Collapse
Affiliation(s)
- J Barallobre-Barreiro
- King's College London, James Black Centre , London , United Kingdom of Great Britain & Northern Ireland
| | - T Radovits
- Semmelweis University Heart and Vascular Center , Budapest , Hungary
| | - M Fava
- King's College London, James Black Centre , London , United Kingdom of Great Britain & Northern Ireland
| | - L Daroczi
- Semmelweis University Heart and Vascular Center , Budapest , Hungary
| | - M Hasman
- King's College London, James Black Centre , London , United Kingdom of Great Britain & Northern Ireland
| | - L Schmidt
- King's College London, James Black Centre , London , United Kingdom of Great Britain & Northern Ireland
| | - F Baig
- King's College London, James Black Centre , London , United Kingdom of Great Britain & Northern Ireland
| | - K Theofilatos
- King's College London, James Black Centre , London , United Kingdom of Great Britain & Northern Ireland
| | - MG Crespo-Leiro
- A Coruña University Hospital, Advanced Heart Failure and Transplantation Unit , A Coruña , Spain
| | - N Domenech
- A Coruña University Hospital, INIBIC , A Coruña , Spain
| | - B Merkely
- Semmelweis University Heart and Vascular Center , Budapest , Hungary
| | - M Mayr
- King's College London, James Black Centre , London , United Kingdom of Great Britain & Northern Ireland
| |
Collapse
|
25
|
Olah A, Bodi B, Sayour AA, Barta BA, Ruppert M, Bottlik O, Merkely B, Papp Z, Radovits T. Exercise-induced right ventricular alterations in a rodent model of athletes heart. Cardiovasc Res 2022. [DOI: 10.1093/cvr/cvac066.044] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Funding Acknowledgements
Type of funding sources: Private grant(s) and/or Sponsorship. Main funding source(s): János Bolyai Research Scholarship of the Hungarian Academy of Sciences (BO/00837/21) to AO
National Research, Development and Innovation Office (NKFIH) of Hungary (K120277 and K135076 to BM)
Background
Intense sports activity leads to the adaptation of cardiac structure and function, the so-called athlete’s heart. Research over the last years has focused on exercise-induced adaptation of the right ventricle (RV), because the disproportionate load on the RV - when compared with left ventricle - might lead to pathological consequences, such as interstital fibrosis or chamber dilation.
Purpose
We aimed at investigating right ventricular alterations induced by regular aerobic exercise training in a rat model of athlete's heart.
Methods
Young, adult rats were divided into control (Co) and exercised (Ex) groups. Trained rats swam 200 min/day for 12 weeks. In vivo electrophysiological study and in vitro force measurements on isolated permeabilized cardiomyocytes were carried out to investigate electrical and functional alterations, respectively. Molecular biological (qRT-PCR, Western-blot) and histological investigations were applied to reveal underlying mechanisms.
Results
Exercise training was associated with increased RV cardiomyocyte width (12.5±0.1µm Co vs. 13.8±0.2µm Ex, p<0.05) and corresponding hyperphosphorylation of protein kinase B (Akt). RV myofilaments from exercised animals showed increased maximal force development and improved calcium sensitivity. Sarcomere protein investigations revealed marked overall and site-specific hypophosphorylation of troponin I. We found prolonged QT interval and right ventricular effective refracter period (RVERP: 44.0±1.6ms Co vs. 52.8±2.1ms Ex, p<0.05) along with decreased gene expression of potassium channels. Picrosirius staining did not reveal fibrosis, that was underlied by unchanged protein expression of connective tissue growth factor (CTGF) and gene expression of profibrotic markers. Gene expression of apoptotic markers and fetal gene program did not differ between the groups.
Conclusions
According to our data, regular swim training induced RV hypertrophy, that was associated with functional improvement adn hypophosphorilation of troponin I. Prolonged repolarization without pathological alterations in RV myocardial tissue suggest physiological remodeling after balanced training.
Collapse
Affiliation(s)
- A Olah
- Semmelweis University, Heart and Vascular Center , Budapest , Hungary
| | - B Bodi
- University of Debrecen, Department of Cardiology, Division of Clinical Physiology , Debrecen , Hungary
| | - AA Sayour
- Semmelweis University, Heart and Vascular Center , Budapest , Hungary
| | - BA Barta
- Semmelweis University, Heart and Vascular Center , Budapest , Hungary
| | - M Ruppert
- Semmelweis University, Heart and Vascular Center , Budapest , Hungary
| | - O Bottlik
- Semmelweis University, Heart and Vascular Center , Budapest , Hungary
| | - B Merkely
- Semmelweis University, Heart and Vascular Center , Budapest , Hungary
| | - Z Papp
- University of Debrecen, Department of Cardiology, Division of Clinical Physiology , Debrecen , Hungary
| | - T Radovits
- Semmelweis University, Heart and Vascular Center , Budapest , Hungary
| |
Collapse
|
26
|
Gergely T, Kucsera D, Toth VE, Petrovich B, Agg B, Onodi ZS, Ruppert M, Radovits T, Merkely B, Ferdinandy P, Varga ZV. Immune checkpoint inhibition with PD-1 inhibitor induces cardiac dysfunction without overt myocarditis in C57BL/6J mice. Cardiovasc Res 2022. [DOI: 10.1093/cvr/cvac066.081] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Funding Acknowledgements
Type of funding sources: Public grant(s) – EU funding. Main funding source(s): European Union’s Horizon 2020 Research and Innovation Programme under grant agreement no. 739593
“Semmelweis 250+ Kiválósági PhD Ösztöndíj” (EFOP-3.6.3-VEKOP-16-2017-00009)
Gedeon Richter Talentum Foundation’s scholarship
Background
Immune checkpoint inhibitors have revolutionized the treatment of several form of malignancies (including metastatic melanoma) by enhancing the cytotoxic effects of T cells against cancer cells. Cancer cells evade immune surveillence by increasing the expression of T cell inhibitory molecules, also known as immune checkpoints, such as programmed cell death-1 (PD-1). Pharmacological inhibition of these molecules by immune checkpoint inhibitors (ICI) will enhance the antitumor activity of T cells. However, enhanced T cell activity may cause immune related adverse effects, including cardiotoxicity.
Aims
We aimed to investigate the effect of PD-1 inhibition on cardiac function and the underlying mechanisms in mice.
Methods
8-10 weeks old C57BL6/J mice were treated with isotype control or anti-PD-1 antibody for 2 or 4 weeks. Cardiac function and morphology was assessed by echocardiography and histology, while the transcriptomic changes were analyzed via RNA sequencing. Nitrosative stress in the heart was assessed by immunohistochemistry and qRT-PCR. Inflammatory gene expression alterations were determined by qRT-PCR in the heart and thymus.
Results
Small animal echocardiography revealed cardiac dysfunction even after 2 weeks of anti-PD-1 treatment, with distinct transcriptomic changes. Nitrosative stress was found to be elevated in the myocardium due to anti-PD-1 treatment, however, histological and qRT-PCR analysis did not reveal T cell infiltration into the myocardium and only mild inflammation was seen in the heart. In contrast, inflammatory gene expression was significantly enhanced in the thymus of anti-PD-1-treated animals, where interleukin-17 showed the most prominent increase.
Conclusions
These findings characterize cardiac dysfunction as a form of ICI-induced cardiotoxicity, which may be mediated by increased thymic inflammatory activation and cytokine production.
Collapse
Affiliation(s)
- T Gergely
- Semmelweis University, Department of Pharmacology and Pharmacotherapy , Budapest , Hungary
| | - D Kucsera
- Semmelweis University, Department of Pharmacology and Pharmacotherapy , Budapest , Hungary
| | - VE Toth
- Semmelweis University, Department of Pharmacology and Pharmacotherapy , Budapest , Hungary
| | - B Petrovich
- Semmelweis University, Department of Pharmacology and Pharmacotherapy , Budapest , Hungary
| | - B Agg
- Semmelweis University, Department of Pharmacology and Pharmacotherapy , Budapest , Hungary
| | - ZS Onodi
- Semmelweis University, Department of Pharmacology and Pharmacotherapy , Budapest , Hungary
| | - M Ruppert
- Semmelweis University, Heart and Vascular Center , Budapest , Hungary
| | - T Radovits
- Semmelweis University, Heart and Vascular Center , Budapest , Hungary
| | - B Merkely
- Semmelweis University, Heart and Vascular Center , Budapest , Hungary
| | - P Ferdinandy
- Semmelweis University, Department of Pharmacology and Pharmacotherapy , Budapest , Hungary
| | - ZV Varga
- Semmelweis University, Department of Pharmacology and Pharmacotherapy , Budapest , Hungary
| |
Collapse
|
27
|
Sayour AA, Ruppert M, Olah A, Barta BA, Zsary E, Benke K, Horvath EM, Hartyanszky I, Merkely B, Radovits T. Left ventricular SGLT1 expression is upregulated in heart failure in humans and rat model. Cardiovasc Res 2022. [DOI: 10.1093/cvr/cvac066.082] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Funding Acknowledgements
Type of funding sources: Public grant(s) – National budget only. Main funding source(s): National Research, Development and Innovation Fund of Hungary;
Ministry of Human Capacities of Hungary
Introduction
Myocardial sodium-glucose cotransporter 1 (SGLT1) has been shown to contribute to cardiac pathological processes, whereas humans with functionally limited SGLT1 are at lower risk of developing heart failure (HF). The novel HF medications, SGLT2 inhibitors, non-selectively inhibit SGLT1 to different extent, therefore, characterization of its expression in disease conditions is relevant.
Purpose
To investigate left ventricular (LV) SGLT1 expression in humans with end-stage HF, and in a rat model of HF.
Methods
Myocardial LV samples were harvested from control subjects (Controls, n=9) undergoing valve surgery, and from patients with end-stage dilated cardiomyopathy (DCM, n=12) undergoing heart transplantation. The rat model of aorto-caval fistula (ACF, n=12) was used to induce HF with predominant LV dilation in rats during a course of 24 weeks; sham-operated animals served as controls (Sham-A, n=12). Echocardiography was used to assess LV structure and function prior to surgery in humans, as well as in rats at the end of the follow-up period. Western blotting was performed to characterize LV SGLT1 protein expression and to investigate the activity of the master regulators AMPK and ERK1/2. The extent of LV nitro-oxidative stress was quantified by immunohistochemistry (3-nitrotyrosine) in rats with HF.
Results
Both humans with DCM and rats with ACF-induced HF presented with severely dilated LVs compared to respective controls, whereas LV SGLT1 protein expression was significantly upregulated similarly by ~1.7-fold in both cases (both P<0.01). These increases in SGLT1 expressions were accompanied by significant reductions in ERK1/2 activating phosphorylation (both P<0.05), whereas AMPK activity was unaffected. In rats with HF, LV SGLT1 expression correlated significantly with the extent of myocardial nitro-oxidative stress (r=0.762, P=0.037).
Conclusions
LV SGLT1 expression is upregulated in HF in both humans and small animals, and ERK1/2 shows a concomitantly reduced activity. LV SGLT1 expression correlates with the extent of nitro-oxidative stress, suggesting a possible pathological role in HF. Whether SGLT2 inhibitors exert direct cardiac actions via inhibition of myocardial SGLT1 needs to be elucidated.
Collapse
Affiliation(s)
- AA Sayour
- Semmelweis University Heart and Vascular Center , Budapest , Hungary
| | - M Ruppert
- Semmelweis University Heart and Vascular Center , Budapest , Hungary
| | - A Olah
- Semmelweis University Heart and Vascular Center , Budapest , Hungary
| | - BA Barta
- Semmelweis University Heart and Vascular Center , Budapest , Hungary
| | - E Zsary
- Semmelweis University Heart and Vascular Center , Budapest , Hungary
| | - K Benke
- Semmelweis University Heart and Vascular Center , Budapest , Hungary
| | - EM Horvath
- Semmelweis University, Department of Physiology , Budapest , Hungary
| | - I Hartyanszky
- Semmelweis University Heart and Vascular Center , Budapest , Hungary
| | - B Merkely
- Semmelweis University Heart and Vascular Center , Budapest , Hungary
| | - T Radovits
- Semmelweis University Heart and Vascular Center , Budapest , Hungary
| |
Collapse
|
28
|
Ruppert M, Korkmaz-Icoz S, Agg B, Sayour AA, Olah A, Nagy D, Benke K, Ferdinandy P, Merkely B, Szabo G, Radovits T. The development of systolic heart failure in case of pressure overload-induced left ventricular myocardial hypertrophy is associated with a unique microRNA expression profile in a rat model. Cardiovasc Res 2022. [DOI: 10.1093/cvr/cvac066.105] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Funding Acknowledgements
Type of funding sources: Public grant(s) – National budget only. Main funding source(s): New National Excellence Program of the Ministry of Human Capacities
Introduction
Growing body of evidence suggests that distinct alterations in myocardial microRNA (miRNA) expression contribute to pressure overload (PO)-induced pathological cardiac remodeling. Nevertheless, it is still under intense investigation whether the changes in miRNA expression patterns are also associated with the decompensation of LV systolic function in case of PO-evoked LV hypertrophy (LVH). Hence, we aimed to characterize miRNA expression in PO-induced LVH with and without systolic heart failure (HF).
Methods
PO was evoked by abdominal aortic banding (AB) in male Sprague-Dawley rats. Age-matched, sham-operated animals served as controls. Functional and morphological alterations were assessed by echocardiography and histology. At the end of the experimental period, rats in the AB group were subcategorized based on ejection fraction [EF] into ABLVH (EF>40%) and ABHF groups (EF<40%). Global miRNA expression profiling was performed using next generation sequencing. Bioinformatics analysis was carried out to predict miRNA-target interactions. Expression of selected target genes was measured by qRT-PCR.
Results
Increased heart weight-to-tibial length, LV mass and fibrosis confirmed the development of pathological LVH in both the ABLVH and ABHF groups. Nevertheless, increased lung weight-to-tibial length, chamber dilatation and severely reduced EF was noted only in the ABHF and not in the ABLVH, when compared to the sham group. 50 miRNA showed different expression in the ABHF compared to the ABLVH group. Based on the altered gene expression profile, in silico bioinformatics analysis predicted several target genes. Among them, reduced mRNA expression level of Fmr1 (FMRP translational regulator 1), Zfpm2 (zinc finger protein, multitype 2), Wasl (WASP like actin nucleation promoting factor), Ets1 (ETS proto-oncogene 1) and Atg16l1 (Autophagy Related 16 Like 1) was confirmed in ABHF compared to ABLVH.
Conclusions
Decompensation of systolic function in PO-induced LVH is associated with unique miRNA profile leading to specific regulation of gene expression.
Collapse
Affiliation(s)
- M Ruppert
- Semmelweis University Heart and Vascular Center , Budapest , Hungary
| | - S Korkmaz-Icoz
- University Hospital Heidelberg, Department of Cardiothoracic Surgery , Heidelberg , Germany
| | - B Agg
- Semmelweis University, Department of Pharmacology and Pharmacotherapy , Budapest , Hungary
| | - AA Sayour
- Semmelweis University Heart and Vascular Center , Budapest , Hungary
| | - A Olah
- Semmelweis University Heart and Vascular Center , Budapest , Hungary
| | - D Nagy
- Semmelweis University Heart and Vascular Center , Budapest , Hungary
| | - K Benke
- Semmelweis University Heart and Vascular Center , Budapest , Hungary
| | - P Ferdinandy
- Semmelweis University, Department of Pharmacology and Pharmacotherapy , Budapest , Hungary
| | - B Merkely
- Semmelweis University Heart and Vascular Center , Budapest , Hungary
| | - G Szabo
- University Hospital Heidelberg, Department of Cardiothoracic Surgery , Heidelberg , Germany
| | - T Radovits
- Semmelweis University Heart and Vascular Center , Budapest , Hungary
| |
Collapse
|
29
|
Eszlari N, Bagyura Z, Millinghoffer A, Nagy T, Juhasz G, Antal P, Merkely B, Bagdy G. Body mass index and depressive rumination are positively associated with each other only in case of GG genotype of catenin alpha 2 gene rs13412541 variant. Eur Psychiatry 2022. [PMCID: PMC9562936 DOI: 10.1192/j.eurpsy.2022.592] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/23/2022] Open
Abstract
Introduction Catenin alpha 2 gene (CTNNA2) is important in the stability of hippocampal synapses and also in brain development. Our recent paper (Eszlari et al, Pharmaceuticals 2021, 14, 850) has demonstrated that rumination on sad mood mediates the association of CTNNA2 only towards psychiatric symptoms, but not towards cardiovascular risk phenotypes. Objectives Our present aim was to test the moderating role of rumination and its two subtypes, brooding and reflection, in genetic associations between CTNNA2 and the same cardiovascular risk phenotypes. Methods 633 unrelated subjects from the Budakalasz Health Examination Survey with non-missing phenotypic data, and 160 single-nucleotide CTNNA2 variants remaining after quality control, were included. Linear regression models were run in Plink 1.9 for separate outcomes of body mass index (BMI), and Framingham risk scores for cardiovascular disease, coronary heart disease, myocardial infarction, and stroke. With each variant, predictors were the variant, rumination or its subtype, the variant x rumination interaction, sex, age, and the top ten principal components of the genome. 100,000 label-swapping max(T) permutation was applied for the interaction term within each analysis. Results While no significant interaction term survived the familywise permutation, two trends emerged. Namely, BMI seems to have positive association with rumination and its maladaptive brooding subtype only in case of GG genotype of rs13412541, otherwise no association can be detected. Conclusions Although replication is needed in larger samples, the relationship between rumination and BMI, conditional on CTNNA2 genotype, can be important in atypical depression, thus may contribute to stratification of depressed patients. Disclosure The study was supported by the New National Excellence Program of the Ministry for Innovation and Technology from the source of the National Research, Development and Innovation Fund (ÚNKP-21-4-II-SE-1); and by 2019-2.1.7-ERA-NET-2020-00005.
Collapse
|
30
|
Maglia G, Bollmann A, Theuns DA, Bar-Lev D, Anguera I, Ayala Paredes FA, Arnold M, Geller JC, Merkely B, Dyrda KM, Perings C, Ploux S, Meyhoefer J, Timmel T, Hindricks G. Real-world experience on implantation and atrial signal detection of a SC ICD with atrial sensing capability: The MATRIX study. Europace 2022. [DOI: 10.1093/europace/euac053.469] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Funding Acknowledgements
Type of funding sources: Private company. Main funding source(s): BIOTRONIK, Berlin, Germany
Introduction
A single-lead implantable cardioverter-defibrillator (ICD) with atrial sensing dipole (the DX ICD system) can potentially give additive information concerning atrial diagnostics in patients requiring only a single-chamber ICD. We therefore report the real-world experience from large DX registry on implantation, atrial signal quality and detection and the long-term stability of the atrial signal.
Methods
The prospective, single-arm MATRIX (Management and Detection of Atrial Tachyarrhythmias in Patients Implanted With BIOTRONIK DX Systems, NCT01774357) registry study effectively enrolled 2041 patients at 119 sites in 24 countries. All patients had a DX system implanted for a single-chamber ICD indication for primary or secondary prevention of sudden cardiac death. Patients were followed for 24 months including remote monitoring. Implantation and follow-up data are reported for the whole patient set. For the analyses on atrial sensing amplitude values, remotely transmitted device measurements of patients without history of long-standing persistent or permanent AF at baseline were used.
Results
The mean follow-up period was 677±173 days. Implantation took place at 15±22 days before enrollment. Baseline and implantation data are shown in the table. Implantation procedure and lead insertion were rated as "easy" or "very easy" in 91.0% and 96.3% of assessments, respectively. At implantation, the investigators rated the quality of the atrial sensing amplitude as "sufficient" in 97% of the assessed cases. At enrollment (12-month/24-month follow-up), the atrial signal quality and detection were rated as "good" or "excellent" in 92.3% (89.8%/89.9%) and 92.4% (90.1%/91.3%) of assessments, respectively. For 1841 patients (90.2%), remotely transmitted device information was received. The median (mean ± SD, IQR) transmission rate was 92.5% (85.4±18.2%, 81.4-97.3%). 1746 patients (85.5%) matched the inclusion criteria for the quantitative analyses on atrial sensing. 95.6% of available RA sensing amplitude values were ≥1 mV. Based on each patient’s overall median value, the median (mean ± SD, IQR) RA sensing amplitude was 4.6 mV (4.4±2.0 mV, 2.8-6.2 mV). The time course of patient median values stratified by month is shown in the figure.
Conclusion
The study followed 2041 patients implanted with the DX ICD system for two years. In the vast majority of cases, investigators rated implantation as (very) easy and the atrial signal over 24 months as good/excellent. According to daily, automatic Home Monitoring data, the overall mean P-wave amplitude remained stable throughout the whole follow-up. The MATRIX study demonstrated functionality and clinical utility of the DX concept in an unselected, real-life setting.
Collapse
Affiliation(s)
- G Maglia
- Azienda Ospedaliera Pugliese-Ciaccio, Catanzaro, Italy
| | - A Bollmann
- Heart Center of Leipzig, Department of Electrophysiology, Leipzig, Germany
| | - DA Theuns
- Erasmus University Medical Centre, Rotterdam, Netherlands (The)
| | - D Bar-Lev
- Chaim Sheba Medical Center, Tel Hashomer, Israel
| | - I Anguera
- University Hospital of Bellvitge, Heart Diseases Institute, Barcelona, Spain
| | | | - M Arnold
- University hospital Erlangen, Erlangen, Germany
| | - JC Geller
- Central Clinic Bad Berka, Bad Berka, Germany
| | - B Merkely
- Semmelweis University, Budapest, Hungary
| | - KM Dyrda
- University of Montreal, Montreal Heart Institute, Montreal, Canada
| | - C Perings
- St.-Marien-Hospital, Luenen, Germany
| | - S Ploux
- Haut-Leveque Hospital - University Hospital Centre, Pessac, France
| | - J Meyhoefer
- Maria Heimsuchung Caritas-Clinic Pankow, Berlin, Germany
| | - T Timmel
- Biotronik SE & Co. KG, Berlin, Germany
| | - G Hindricks
- Heart Center of Leipzig, Department of Electrophysiology, Leipzig, Germany
| |
Collapse
|
31
|
Szegedi N, Perge P, Sallo Z, Piros K, Nagy VK, Osztheimer I, Merkely B, Geller L. The role of local impedance drop in the acute lesion efficacy during pulmonary vein isolation performed with a new contact force sensing catheter. Europace 2022. [DOI: 10.1093/europace/euac053.220] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Abstract
Abstract
Funding Acknowledgements
Type of funding sources: None.
Background
Pulmonary vein isolation (PVI) is the cornerstone treatment for paroxysmal atrial fibrillation (AF). The effective lesion creation during the PVI is essential to reach optimal long-term results.
Purpose
Our pilot study aimed to evaluate the role of local impedance drop in lesion formation during pulmonary vein isolation with a novel contact force sensing ablation catheter that records local impedance as well and to find a local impedance cut-off value that predicts successful lesion formation.
Materials and methods
After completing point-by-point radiofrequency pulmonary vein isolation, the success of the applications was evaluated by pacing along the ablation line at 10 mA, 2 ms pulse width. Lesions were considered successful if loss of local capture was achieved.
Results
Out of 645 applications, 561 were successful and 84 were unsuccessful. Compared to the unsuccessful ablation points, the successful applications were shorter (p=0.0429) and had a larger local impedance drop (p<0.0001). There was no difference between successful and unsuccessful applications in terms of mean contact force (p=0.8571), force-time integral (p=0.0699) and contact force range (p=0.0519). The optimal cut-point for the local impedance drop indicating successful lesion formation was 21.80 Ohms on the anterior wall [AUC=0.80 (0.75-0.86), p<0.0001], and 18.30 Ohms on the posterior wall [AUC=0.77 (0.72-0.83), p<0.0001]. A local impedance drop larger than 21.80 Ohms on the anterior wall and 18.30 Ohms on the posterior wall was associated with an increased probability of effective lesion creation [OR=11.21, 95%CI 4.22–29.81, p<0.0001; and OR=7.91, 95%CI 3.77–16.57, p<0.0001, respectively].
Conclusion
The measurement of the local impedance may predict optimal lesion formation. A local impedance drop > 21.80 Ohms on the anterior wall and > 18.30 Ohms on the posterior wall significantly increases the probability of creating a successful lesion.
Collapse
Affiliation(s)
- N Szegedi
- Semmelweis University Heart and Vascular Center, Budapest, Hungary
| | - P Perge
- Semmelweis University Heart and Vascular Center, Budapest, Hungary
| | - Z Sallo
- Semmelweis University Heart and Vascular Center, Budapest, Hungary
| | - K Piros
- Semmelweis University Heart and Vascular Center, Budapest, Hungary
| | - VK Nagy
- Semmelweis University Heart and Vascular Center, Budapest, Hungary
| | - I Osztheimer
- Semmelweis University Heart and Vascular Center, Budapest, Hungary
| | - B Merkely
- Semmelweis University Heart and Vascular Center, Budapest, Hungary
| | - L Geller
- Semmelweis University Heart and Vascular Center, Budapest, Hungary
| |
Collapse
|
32
|
Veres B, Schwertner WR, Engh M, Masszi R, Kuthi L, Behon A, Merkel ED, Osztheimer I, Fehervari P, Ghare S, Pinter A, Zima E, Hegyi P, Kosztin A, Merkely B. The benefits of adding a defibrillator to cardiac resynchronization therapy - Systematic review and meta-analysis. Europace 2022. [DOI: 10.1093/europace/euac053.506] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Funding Acknowledgements
Type of funding sources: Other. Main funding source(s): The research presented here, carried out by Semmelweis University was supported by Semmelweis 250+ Excellence Scholarship (EFOP-3.6.3-VEKOP-16-2017-00009)as well as the Centre for Translational Medicine, Semmelweis University. This work was financed by the Thematic Excellence Programme (2020-4.1.1.-TKP2020) of the Ministry for Innovation and Technology in Hungary, within the framework of the Therapeutic Development and Bioimaging thematic programmes of the Semmelweis University.
Background
There is an enduring controversy whether cardiac resynchronisation therapy-defibrillation (CRT-D) is preferred over CRT-pacemaker (CRT-P). No head-to-head randomised controlled trials have been designed to compare the treatments. However, several observational studies were performed during previous years, but they got controversial results.
Methods
PubMed, CENTRAL and Embase until October 2021 were screened for studies comparing CRT-P and CRT-D, focusing on all-cause mortality, cardiovascular mortality, sudden cardiac death, and non-cardiac death. Both interventional and observational studies comparing CRT-D and CRT-P patients were included. Studies only available as conference abstracts were excluded. Odds ratio with 95% confidence interval (CI) was calculated, data from the selected studies were pooled using a random effect model (Mantel-Haenszel method, where more than 5 studies with Hartung-Knapp adjustment). τ2 was estimated by Paule-Mandel method with CI calculated by Q profile method. Statistical heterogeneity was assessed by Cochrane Q test and I2 test. Results were summarized by Forest and drapery plots.
Results: 16 observational studies(57,337 patients) were included(CRT-P: 32 591, CRT-D: 24 746). CRT-D was superior to CRT-P regarding all-cause mortality in univariate analysis(HR:0.73; 95% CI:0.64-0.83; p <0.01). The between-study heterogeneity (I2) value was not significant. The random-effects τ2 value was 0.02 (95% CI:0-0.06). Three studies(47,846 patients, CRT-P: 27,344, CRT-D: 20,502) compared cardiovascular mortality between CRT-D and CRT-P. Univariate analysis showed a significantly lower rate of cardiovascular mortality in patients implanted with a CRT-D device compared to patients with a CRT-P device.(HR:0.61; 95% CI:0.50-0.73; p=0.002) Five studies (6,434 patients. CRT-P:3,475, CRT-D:2,959) were analyzed for sudden cardiac death, CRT-D was superior in univariate analysis(HR:0.33; 95% CI:0.28-0.89; p=0.03). Three studies (4,623 patients. CRT-P:2,518, CRT-D:2,105) reported on heart failure death, CRT-D was associated with decreased heart failure mortality compared to CRT-P(HR:0.68; 95% CI: 0.41-0.95; p=0.008). Three studies(48,770 patients ,CRT-P:28,398, CRT-D: 20,372) reported on non-cardiac death, CRT-D showed significantly better survival than CRT-P(HR:0.58; 95% CI:0.55-0.60; p<0.0001).
Conclusion: Our work demonstrates an association between CRT-D and lower all-cause mortality, cardiovascular and heart failure mortality, sudden cardiac death, and non-cardiac death. However, due to the heterogeneity of the articles coming from the selection bias of patients for CRT-D/CRT-P implantation, this question requires further analysis.
Collapse
Affiliation(s)
- B Veres
- Semmelweis University, Budapest, Hungary
| | | | - M Engh
- Semmelweis University, Budapest, Hungary
| | - R Masszi
- Semmelweis University, Budapest, Hungary
| | - L Kuthi
- Semmelweis University, Budapest, Hungary
| | - A Behon
- Semmelweis University, Budapest, Hungary
| | - ED Merkel
- Semmelweis University, Budapest, Hungary
| | | | | | - S Ghare
- Semmelweis University, Budapest, Hungary
| | - A Pinter
- Semmelweis University, Budapest, Hungary
| | - E Zima
- Semmelweis University, Budapest, Hungary
| | - P Hegyi
- Semmelweis University, Budapest, Hungary
| | - A Kosztin
- Semmelweis University, Budapest, Hungary
| | - B Merkely
- Semmelweis University, Budapest, Hungary
| |
Collapse
|
33
|
Schwertner WR, Tokodi M, Behon A, Veres B, Merkel E, Kuthi L, Masszi R, Kovacs A, Zima E, Geller L, Osztheimer I, Kosztin A, Merkely B. Pacemaker upgrade to Cardiac Resynchronization Therapy-defibrillator or Cardiac Resynchronization Therapy-pacemaker without prior ventricular arrhythmias. Europace 2022. [DOI: 10.1093/europace/euac053.486] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Funding Acknowledgements
Type of funding sources: Public grant(s) – National budget only. Main funding source(s): This work was supported by the ÚNKP-21-3-II-SE-47, ÚNKP-20-3-I-SE-43 New National Excellence Program if the Ministry for Innovation and Technology in Hungary. Project no. NVKP_16-1–2016-0017 (’National Heart Program’) has been implemented with the support provided by the National Research, Development and Innovation Fund of Hungary, funded under the NVKP_16 funding scheme. The research was financed by the Thematic Excellence Programme (2020-4.1.1.-TKP2020) of the Ministry for Innovation and Technology in Hungary, within the framework of the Therapeutic Development and Bioimaging thematic programmes of the Semmelweis University. This work was also supported by the Semmelweis 250+ Excellence PhD Scholarship (EFOP-3.6.3-VEKOP-16-2017-00009).
Background
Cardiac Resynchronization Therapy (CRT) can reverse the harmful effects of right ventricular pacing (RVP). Data are scarce on comparing long-term survival among patients who undergone CRT-defibrillator (CRT-D) or CRT-pacemaker (CRT-P) upgrade from pacemakers (PM) without prior ventricular arrhythmias (VAs).
Purpose
We compared the differences in long-term all-cause mortality among PM patients receiving CRT-D or CRT-P upgrade.
Methods
Patients with conventional PMs developing heart failure despite optimal medical treatment and a high rate of RVP with no prior VAs were included. Altogether 326 patients were investigated, 117 (36%) upgraded to CRT-D, 209 (64%) to CRT-P in our retrospective registry. The primary endpoint was all-cause mortality. Subgroup analyses were performed by comorbidities and CRT device types. Using topological data analysis, we identified risk groups based on the primary endpoint.
Results
During the median follow-up time of 3.6 years, 33 (28%) CRT-D and 145 (69%) of CRT-P upgrade patients reached the primary endpoint. The CRT-D upgrade group showed a lower risk of all-cause mortality in the total cohort (HR: 0.55; 95% CI: 0.38-0.81; p=0.002) and by ischaemic aetiology (HR: 0.47; 95% CI: 0.29-0.76; p=0.002) compared to CRT-P. After adjustment, CRT-D, male gender and loop diuretics proved as independent predictors of all-cause mortality. Patients upgraded with CRT-D demonstrated favourable survival in the high-risk group over CRT-P.
Conclusions
Patients had survival benefit after CRT-D upgrade, compared to CRT-P, in the high-risk group and with ischaemic heart failre aetiology. However, no difference could be observed between the two groups among low- and intermediate-risk patients.
Collapse
Affiliation(s)
- W R Schwertner
- Semmelweis University Heart and Vascular Center, Budapest, Hungary
| | - M Tokodi
- Semmelweis University Heart and Vascular Center, Budapest, Hungary
| | - A Behon
- Semmelweis University Heart and Vascular Center, Budapest, Hungary
| | - B Veres
- Semmelweis University Heart and Vascular Center, Budapest, Hungary
| | - E Merkel
- Semmelweis University Heart and Vascular Center, Budapest, Hungary
| | - L Kuthi
- Semmelweis University Heart and Vascular Center, Budapest, Hungary
| | - R Masszi
- Semmelweis University Heart and Vascular Center, Budapest, Hungary
| | - A Kovacs
- Semmelweis University Heart and Vascular Center, Budapest, Hungary
| | - E Zima
- Semmelweis University Heart and Vascular Center, Budapest, Hungary
| | - L Geller
- Semmelweis University Heart and Vascular Center, Budapest, Hungary
| | - I Osztheimer
- Semmelweis University Heart and Vascular Center, Budapest, Hungary
| | - A Kosztin
- Semmelweis University Heart and Vascular Center, Budapest, Hungary
| | - B Merkely
- Semmelweis University Heart and Vascular Center, Budapest, Hungary
| |
Collapse
|
34
|
Komlosi F, Toth P, Vamosi P, Szegedi N, Sallo Z, Piros K, Perge P, Osztheimer I, Abraham P, Szeplaki G, Merkely B, Geller L, Nagy VK. Factors predicting repeated ablation in ventricular tachycardia patients. Europace 2022. [DOI: 10.1093/europace/euac053.080] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Funding Acknowledgements
Type of funding sources: Public grant(s) – National budget only. Main funding source(s): National Heart Program
Background
Catheter ablation has emerged to be the principal treatment for recurrent ventricular tachycardia (VT). Previously, several predictors of VT recurrence have been described, such as LVESD, severe MR, incessant VT, ICD shocks and elevated LDH levels. However, factors predicting an additional ablation are unknown.
Purpose
We aimed to establish predictors of repeat ablation and compare to the predictors of ventricular arrhythmia recurrence during 1-year follow-up in structural heart disease.
Methods
Baseline medical history, laboratory results, imaging parameters, clinical properties of VTs, and procedural data were gathered in a structured database.
Results
Out of the 272 patients, 96 (35%) experienced recurrence and 36 (13%) had repeated procedures within 1 year. Independent predictors of recurrence were left ventricular end systolic diameter (HR = 1.516, p=0.015), severe mitral regurgitation (HR = 2.446, p = 0.002), incessant VT (HR = 1.64, p = 0.02), VT inducibility (HR = 3.71, p = 0.003), ICD shocks (HR = 1.95, p = 0.002) and elevated LDH levels (HR = 1.26, p = 0.003). Regarding redo ablation, elevated LDH level (HR = 1.64, p = 0.01), incessant VT (HR = 2.94, p < 0.001), ICD shocks (HR = 2.38, p = 0.02), only exit point ablation (HR = 2.14, p = 0.023) were independent predictors, while hypertension (HR = 0.32, p = 0.03), longer transmitral E-wave deceleration time (HR = 0.47, p = 0.04), substrate modification (HR = 0.47, p = 0.044) were protective.
Conclusion
Predictors of repeat ablation overlap only partially with those of VT recurrence. Predictors implying higher risk VT episodes predict both recurrence and repeat ablation while factors associated with more severe left ventricular systolic dysfunction predict recurrence but not a redo procedure.
Collapse
Affiliation(s)
- F Komlosi
- Semmelweis University, Budapest, Hungary
| | - P Toth
- Semmelweis University, Budapest, Hungary
| | - P Vamosi
- Semmelweis University, Budapest, Hungary
| | - N Szegedi
- Semmelweis University, Budapest, Hungary
| | - Z Sallo
- Semmelweis University, Budapest, Hungary
| | - K Piros
- Semmelweis University, Budapest, Hungary
| | - P Perge
- Semmelweis University, Budapest, Hungary
| | | | - P Abraham
- Semmelweis University, Budapest, Hungary
| | - G Szeplaki
- Mater Private Hospital, Electrophysiology, Dublin, Ireland
| | - B Merkely
- Semmelweis University, Budapest, Hungary
| | - L Geller
- Semmelweis University, Budapest, Hungary
| | - VK Nagy
- Semmelweis University, Budapest, Hungary
| |
Collapse
|
35
|
Lakatos BK, Ruppert M, Ladanyi Z, Fabian A, Ujvari A, Tokodi M, Molnar L, Zima E, Apor A, Nagy A, Kovacs A, Merkely B. Changes of the non-invasive myocardial work in patient undergoing transcatheter aortic valve replacement: the influence of left bundle branch block. Europace 2022. [DOI: 10.1093/europace/euac053.038] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Funding Acknowledgements
Type of funding sources: None.
Patients with left bundle branch block (LBBB) are known to have substantially increased afterload sensitivity. It gains particular importance in subjects with aortic stenosis: patients with pre-existing LBBB may benefit more from interventions such as transcatheter aortic valve replacement (TAVR) by an effective and rapid reduction of the left ventricular (LV) pressures.
Accordingly, our aim was to investigate the changes of LV myocardial work indices in patients undergoing TAVR by the presence of preoperative LBBB. Non-invasive myocardial work indices are novel echocardiographic parameters which adjust LV deformation to the instantaneous LV pressure, overcoming the the load-sensitivity of the traditional LV functional measures.
Thirty patients undergoing TAVR were enrolled (37% female; age: 78±6 years; aortic valve area [AVA]: 0.7±0.3 cm2). Fourteen patients (47%; LBBB group) showed LBBB pattern on ECG, by demonstrating native LBBB (n=6; 20%) or having ventricular pacing dependency (n=8; 27%), while 16 patients had narrow QRS (53%; non-LBBB group). Prior to the procedure, subjects underwent a detailed echocardiographic investigation. Speckle-tracking analysis was performed and global longitudinal strain (GLS) was measured. LV pressure curve was estimated by adding the mean aortic valve gradient to the aortic systolic pressure. Using these measures, LV global constructive work index (CMWI) and global work efficiency (GWE). were quantified by commercially available software. A 6 months follow-up examination was also performed and at that time point we determined the aforementioned parameters.
As expected, AVA significantly improved after the procedure in the pooled study group (1.8±0.4 cm2; p<0.001). GLS also significantly increased (-13.2±4.2 vs. -15.2±3.9 %; p<0.01), while CMWI only showed a tendential decrease (2422±788 vs. 2166±640 mmHg%; p=NS) at the follow-up. GLS (-10.6±3.7 vs. -15.5±3.4%; p<0.001), CMWI (1877±679 vs. 2898±529 mmHg%; p<0.001), and also GWE (82±9 vs. 91±4%; p<0.01) was significantly lower in the LBBB-group compared to the non-LBBB patients. At the follow-up, GLS was still significantly lower in the LBBB patients (-13.2±4.6 vs. -16.9±2.1%; p<0.01), however, CMWI was comparable between the two groups (1956±776 vs. 2350±439 mmHg%, p=NS).
Pressure overload of the LV may affect patients with LBBB substantially more than subjects without it. TAVR causes an immediate and significant decrease in the LV afterload, which results in a more pronounced improvement in the LBBB group compared to those with no LBBB.
Collapse
Affiliation(s)
- BK Lakatos
- Semmelweis University Heart and Vascular Center, Budapest, Hungary
| | - M Ruppert
- Semmelweis University Heart and Vascular Center, Budapest, Hungary
| | - Z Ladanyi
- Semmelweis University Heart and Vascular Center, Budapest, Hungary
| | - A Fabian
- Semmelweis University Heart and Vascular Center, Budapest, Hungary
| | - A Ujvari
- Semmelweis University Heart and Vascular Center, Budapest, Hungary
| | - M Tokodi
- Semmelweis University Heart and Vascular Center, Budapest, Hungary
| | - L Molnar
- Semmelweis University Heart and Vascular Center, Budapest, Hungary
| | - E Zima
- Semmelweis University Heart and Vascular Center, Budapest, Hungary
| | - A Apor
- Semmelweis University Heart and Vascular Center, Budapest, Hungary
| | - A Nagy
- Semmelweis University Heart and Vascular Center, Budapest, Hungary
| | - A Kovacs
- Semmelweis University Heart and Vascular Center, Budapest, Hungary
| | - B Merkely
- Semmelweis University Heart and Vascular Center, Budapest, Hungary
| |
Collapse
|
36
|
Perge P, Sallo Z, Piros K, Nagy VK, Osztheimer I, Merkely B, Geller L, Szegedi N. Early local impedance drop during pulmonary vein isolation using a novel contact force sensing catheter is associated with acute lesion efficacy. Europace 2022. [DOI: 10.1093/europace/euac053.112] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Funding Acknowledgements
Type of funding sources: None.
Introduction
The predictive role of adequate local impedance drop in lesion formation using a novel contact force sensing ablation catheter for pulmonary vein isolation was recently described. The purpose of our pilot study was to assess the temporal characteristics of local impedance drop and its correlation with acute lesion efficacy.
Methods
Point-by-point radiofrequency pulmonary vein isolation was performed with 50 W energy setup in power-controlled mode. The efficacy of applications was assessed by pacing along the circular ablation line. We considered the lesions successful if loss of capture was achieved. Local impedance, contact force and catheter position data of the applications with 10 msec resolution was analysed. The local impedance of successful and unsuccessful applications was compared at baseline and 2, 4, 6, 8 and 10 sec time points, respectively. We characterized the local impedance for each time point with the mean of the 5 impedance value closest in time.
Results
184 applications were analysed, 167 were successful and 17 were unsuccessful. There was no difference in mean contact force (p=0.142) and contact force range (p=0.606) between successful and unsuccessful applications. The baseline local impedance was significantly lower in the unsuccessful group (p<0.0001), while successful applications had significantly larger local impedance drop at the 2 (p=0.0006), 4 (p<0.0001), 6 (p=0.0066), 8 (p=0.016) and 10 sec (p=0.0106) time points compared with the unsuccessful group. Local impedance did not change significantly over time in case of unsuccessful applications (p=0.192), while it decreased significantly in case of successful applications (p<0.0001).
Conclusion
Early rapid drop of the local impedance may predict effective lesion formation, while slowly changing or unchanged local impedance is associated with unsuccessful applications. In case of a slow local impedance drop during the first 6 seconds of radiofrequency application, it might be reasonable to stop the application and start a new one after catheter repositioning.
Collapse
Affiliation(s)
- P Perge
- Semmelweis University, Heart and Vascular Center, Budapest, Hungary
| | - Z Sallo
- Semmelweis University, Heart and Vascular Center, Budapest, Hungary
| | - K Piros
- Semmelweis University, Heart and Vascular Center, Budapest, Hungary
| | - VK Nagy
- Semmelweis University, Heart and Vascular Center, Budapest, Hungary
| | - I Osztheimer
- Semmelweis University, Heart and Vascular Center, Budapest, Hungary
| | - B Merkely
- Semmelweis University, Heart and Vascular Center, Budapest, Hungary
| | - L Geller
- Semmelweis University, Heart and Vascular Center, Budapest, Hungary
| | - N Szegedi
- Semmelweis University, Heart and Vascular Center, Budapest, Hungary
| |
Collapse
|
37
|
Vamosi P, Tokodi M, Toth P, Komlosi F, Osztheimer I, Perge P, Piros K, Sallo Z, Szegedi N, Merkely B, Nagy KV, Geller L. A novel machine learning based algorithm to predict 1-year mortality after ventricular tachycardia ablation. Europace 2022. [DOI: 10.1093/europace/euac053.372] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Funding Acknowledgements
Type of funding sources: Public grant(s) – National budget only. Main funding source(s): -Project no. NVKP_16-1–2016-0017 (’National Heart Program’) has been implemented with the support provided by the Ministry of Innovation and Technology of Hungary from the National Research, Development and Innovation Fund of Hungary, financed under the NVKP_16 funding scheme.
-Project no. MEC_R-141548 has been implemented with the support provided by the Ministry of Innovation and Technology of Hungary from the National Research, Development and Innovation Fund, financed under the MEC_R_21 funding scheme.
Background
Catheter ablation constitutes an established therapeutic option in patients with monomorphic ventricular tachycardia (VT). VT patients have high comorbidity burden and high mortality, however there is big heterogenity among individual patients. Therefore, effective postprocedural risk assessment systems, prediciting the mortality of patients undergoing VT ablation are highly needed.
Purpose
We aimed to develop a risk stratification algorithm predicting the 1-year all-cause mortality of patients undergoing VT ablation, and to identify the most important input factors of the model.
Methods
Between 2005 and 2020, 272 consecutive patients underwent VT ablation due to sustained monomorphic VT at our institution. We processed their procedural, demographic and medical history data, in addition to their laboratory and echocardiographic findings. For the training of different supervised learning models, we used 63 pre-procedural and procedural variables. We performed 5-fold cross validation and calculated the area under the receiver operating characteristic (ROC) curve (AUC), to assess the performance of the models. Finally, with calculating Shapley values we determined the most important factors of the mortality prediction for the best performing model.
Results
After a follow up of one year, total all-cause mortality was 22% (59). In predicting 1-year mortality, the best performance was shown by the random forest model [AUC: 0,73 (0,68-0,78)] among the machine learning models we had trained. This model significantly outperformed the traditional score systems like I-VT [AUC: 0,63 (0,55-0,70) vs. 0,73 (0,68-0,78), p<0,001] and PAINESD [AUC: 0,63 (0,55-0,71) vs. 0,73 (0,68-0,78), p=0,009] in our dataset. The predictive factors with the biggest effect on mortality were mitral E wave deceleration time, presence of cardiac resynchronization therapy, age, electric storm and hemoglobin concentration.
Conclusion
We were able to establish a supervised machine learning based system which managed to predict the 1-year mortality of VT ablation patients with high accuracy and turned out to be superior when compared to the use of existing risk scores. This enables us to identify the patients in need of a more thorough follow-up, which could reduce their mortality.
Collapse
Affiliation(s)
- P Vamosi
- Semmelweis University, Heart and Vascular Center, Budapest, Hungary
| | - M Tokodi
- Semmelweis University, Heart and Vascular Center, Budapest, Hungary
| | - P Toth
- Semmelweis University, Heart and Vascular Center, Budapest, Hungary
| | - F Komlosi
- Semmelweis University, Heart and Vascular Center, Budapest, Hungary
| | - I Osztheimer
- Semmelweis University, Heart and Vascular Center, Budapest, Hungary
| | - P Perge
- Semmelweis University, Heart and Vascular Center, Budapest, Hungary
| | - K Piros
- Semmelweis University, Heart and Vascular Center, Budapest, Hungary
| | - Z Sallo
- Semmelweis University, Heart and Vascular Center, Budapest, Hungary
| | - N Szegedi
- Semmelweis University, Heart and Vascular Center, Budapest, Hungary
| | - B Merkely
- Semmelweis University, Heart and Vascular Center, Budapest, Hungary
| | - KV Nagy
- Semmelweis University, Heart and Vascular Center, Budapest, Hungary
| | - L Geller
- Semmelweis University, Heart and Vascular Center, Budapest, Hungary
| |
Collapse
|
38
|
Sallo Z, Perge P, Piros K, Herczeg SZ, Nagy KV, Osztheimer I, Abraham P, Merkely B, Geller L, Szegedi N. Impact of high-power and very high-power short-duration radiofrequency ablation on procedure characteristics and first-pass isolation during pulmonary vein isolation. Europace 2022. [DOI: 10.1093/europace/euac053.275] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Funding Acknowledgements
Type of funding sources: None.
Introduction
High-power short-duration (HPSD) radiofrequency ablation has been proposed as a method for producing rapid and effective lesions for pulmonary vein isolation.We aimed to evaluate the procedural characteristics and the FPI rate of HPSD and very high-power short-duration (vHPSD) compared to low-power long-duration (LPLD) ablation techniques.
Methods
156 patients with atrial fibrillation (AF) were enrolled and assigned to LPLD, HPSD, or vHPSD PVI. The energy setting was 30W, 50W, and 90W in the LPLD, HPSD, and vHPSD groups, respectively.
Results
Bilateral PVI was achieved in all cases. The procedure time was 85 [75-101] min, 79 [65-91] min, and 70 [53-83] min in the LPLD, HPSD, and vHPSD groups, respectively (p<0,0001). LA dwelling times were also decreased significantly with the increase of RF energy (61 [55-70] min, 53 [41-56] min, and 45 [34-52] min, in the LPLD, HPSD, and vHPSD groups, respectively, p<0.0001). The total RF ablation time was 1398 [1021-1711] sec, 1567 (1366-1761) sec, and 336 [247-386] sec in the LPLP, HPSD, and vHPSD group, respectively ( p<0,0001). Bilateral FPI was rate was 57%, 78% and 80% in the LPLD, HPSD, and vHPSD groups, respectively (p=0,0097). On the left side, FPI was achieved in 66% in the LPLD, in 92% in the HPSD, and in 85% in the vHPSD ablation group (p=0.0015). FPI on the right side was achieved in 72% in the LPLD, in 88% in the HPSD, and in 88% in the vHPSD ablation group (p=0,0188). FPI rates were significantly higher in the HPSD group compared to the LPLD group: both sided FPI rate was 57% vs. 78% (p=0.021), left sided FPI rate was 66% vs. 92% (p=0.0015), and right sided FPI rate was 72% vs. 88% (p=0.0401). Further increase in the RF power did not result in a significant additional increase in the FPI rate. In the HPSD vs. vHPSD group both sided FPI rate was 78% vs. 80% (p=0,8080), left sided FPI rate was 92% vs. 85% (p= 0,5275), and right sided FPI rate was 88% vs. 88% (p= 0,7561). Univariate analysis revealed that the use of HPSD ablation technique is associated with a higher probability of FPI (both sides: OR=2.72, 95% CI 1.15-6.44, p=0.023; right side: OR=2.90, 95% CI 1.02-8.20, p=0.045; left side: OR=5.91, 95% CI 1.84-19.04, p=0.003). The mid-term arrhythmia-free survival was similarly high in all three groups.
Conclusion
Our prospective, observational cohort study showed that both HPSD and vHPSD RF ablation is effective, as it shortens procedure time and RF time and results in a higher rate of FPI compared to LPLD ablation. Moreover, the mid-term arrhythmia-free survival was similarly high in all three groups. In our study, no safety concerns were raised due to HPSD ablation.
Collapse
Affiliation(s)
- Z Sallo
- Semmelweis University Heart and Vascular Center, Budapest, Hungary
| | - P Perge
- Semmelweis University Heart and Vascular Center, Budapest, Hungary
| | - K Piros
- Semmelweis University Heart and Vascular Center, Budapest, Hungary
| | - SZ Herczeg
- Semmelweis University Heart and Vascular Center, Budapest, Hungary
| | - KV Nagy
- Semmelweis University Heart and Vascular Center, Budapest, Hungary
| | - I Osztheimer
- Semmelweis University Heart and Vascular Center, Budapest, Hungary
| | - P Abraham
- Semmelweis University Heart and Vascular Center, Budapest, Hungary
| | - B Merkely
- Semmelweis University Heart and Vascular Center, Budapest, Hungary
| | - L Geller
- Semmelweis University Heart and Vascular Center, Budapest, Hungary
| | - N Szegedi
- Semmelweis University Heart and Vascular Center, Budapest, Hungary
| |
Collapse
|
39
|
Milman A, Nof E, Beinart R, Regev E, Rav Acha M, Kutyifa V, Merkely B, Biffi M, Cha YM, Ovdat T, Klempfner R, Glikson M. Intraoperative defibrillation testing during replacements of implantable cardioverter-defibrillators: The Simpler trial. Europace 2022. [DOI: 10.1093/europace/euac053.461] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Abstract
Abstract
Funding Acknowledgements
Type of funding sources: Foundation. Main funding source(s): Maurice Kahn Foundation via the Mayo- Sheba Collaboration Fund.
Background
The need for intraoperative defibrillation testing (DFT) during implant and/or replacement of implantable cardioverter-defibrillators (ICDs) has been a matter of debate for many years. This debate was put to rest by the Simple and the Nordic ICD trials, and the practice of testing during new implantations has practically been nearly abandoned.
Nevertheless, induction of VF for testing purposes (VFT) may still have an important role in selective populations at risk for defibrillation failure, who were not included in the SIMPLE and Nordic trials. One such population includes those who undergo device replacements. Old registries demonstrated an increased incidence of significant findings in VFT during replacements. In the present study, we sought to test this observation.
Objectives
Evaluate frequency of significant findings and the safety of VFT in subjects undergoing device replacement.
Methods
A prospective observational multi-center study of VFT included consecutive patients undergoing ICD generator replacement in 5 centers in Israel, Europe, and the US. All centers followed the same VFT protocol. The primary outcome was defined as failure to terminate induced VF with a single shock at 10 Joules below the maximal capacity of the device. Secondary outcomes included complications of VFT. Patients were followed-up at 1 month and 6 months post-procedure. Data collection included documentation of any peri-operative complications and clinical endpoints (occurrence of appropriate shock, inappropriate shocks, lead failure, need for re-intervention, and infection).
Results
A total of 92 patients were eligible, and consented for the study, of which 84 underwent DFT during battery replacement. The median age was 68 years and 79.8% were male subjects. Induction of VF was successful in all 84 patients as well as VFT with a successful conversion on first attempt. During follow up one patient had two appropriate ICD shock events. In four patients, the ICD programming was changed. None suffered an inappropriate shock. There was no evidence of lead malfunction. A total of two deaths occurred, none of which were related to the device.
Conclusion
The present study found VFT was not associated with complications in patients undergoing ICD/CRTD generator replacement but produced no clinically important information.
Collapse
Affiliation(s)
- A Milman
- Sheba Medical Center, Tel Hashomer, Israel
| | - E Nof
- Sheba Medical Center, Tel Hashomer, Israel
| | - R Beinart
- Sheba Medical Center, Tel Hashomer, Israel
| | - E Regev
- Sheba Medical Center, Tel Hashomer, Israel
| | - M Rav Acha
- Shaare Zedek Medical Center, Jerusalem, Israel
| | - V Kutyifa
- University of Rochester, Rochester, United States of America
| | - B Merkely
- Semmelweis University Heart and Vascular Center, Budapest, Hungary
| | - M Biffi
- Institute of Cardiology, Bologna, Italy
| | - YM Cha
- Mayo Clinic, Rochester, United States of America
| | - T Ovdat
- Sheba Medical Center, Tel Hashomer, Israel
| | | | - M Glikson
- Shaare Zedek Medical Center, Jerusalem, Israel
| |
Collapse
|
40
|
Masszi R, Merkel E, Schwertner W, Veres B, Behon A, Pinter A, Osztheimer I, Zima E, Geller L, Becker D, Kosztin A, Merkely B. The effect of implantable cardioverter defibrillator in patients with cardiac resynchronizational therapy and diabetes mellitus. Europace 2022. [DOI: 10.1093/europace/euac053.494] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Abstract
Abstract
Funding Acknowledgements
Type of funding sources: Public grant(s) – National budget only. Main funding source(s): (NKFIA; NVKP_16-1-2016-0017 National Heart Program).
Background
Heart failure (HF) and diabetes mellitus (DM) are common causes of death on their own, but the coexistance of these two diseases are especially fatal. 1 In DM, sudden cardiac death (SCD) is more common than in non-DM patients, however in many cases, implantable cardioverter defibrillator (ICD) could not prevent SCD. 2
Purpose
Our aim is to decide which device warrant higher life expectancy, cardiac resynchronizational therapy with or without defibrillator.
Methods
We examined retrospectively 2525 CRT implanted patients, with a mean follow-up time of 4.6 years. Implantaions were based on the current guidelines. The primary endpoint was all-cause mortality, while our composite end-point were all-cause mortality and heart failure hospitalization.
Results
In our population, 928 people (36%) had diabetes. We did not find statistical differences between age (68 vs. 68 years; p<0.099), gender (26% women, 23% women; p<0.08) LVEF (28% vs. 29% p<0.1425), incidence of atrial fibrillation (37% vs. 38%; p<0.76), implantation of an ICD (53% vs. 54%; p<0.847), NT-proBNP median levels (2939 pg/ml vs. 2778 pg/ml; p<0.35), and NYHA I (0,5% vs. 0,5%; p<0.898), and NYHA IV stadium (11% vs. 11%; p<0,82). However DM patients had higher BMI (28 kg/m2 vs. 26 kg/m2; p<0.001), lower eGFR levels (57 ml/min/1,73m2 vs. 60 ml/min/1,73m2; p<0.011) higher prevalence of hypertonia (82% vs. 66%; p<0.001), NYHA III stadium (39% vs. 33%; p<0,0008), ischemic etiology (56% vs. 44%; p<0.001), previous acute myocardial infartion (42,9% vs. 36%; p<0.001), a percutan coronaria intervention (35% vs. 25%; p<0.001) compared to non-DM patients. Those patients with DM showed a 25% higher risk of all-cause mortality (HR 1.25; 95% CI 1.12-1.40; p‹0.01) then non-DM patientes, also observable after adjusting for relevant clinical covariates such as age, gender, atrial fibrillation and the addition of an ICD (HR 1.17; 95% CI 1.06-1.31; p‹0.01).
Conclusions
Adding an ICD for CRT patients with diabetes reduces the risk of all-cause mortality significantly by 32% (HR 0,68; CI 0,56-0,82; p‹0.001) during the first six years but diminished on longer follow-up time (HR 0,95; CI 0,80-1,12; p=0,54).
Collapse
Affiliation(s)
- R Masszi
- Semmelweis University Heart and Vascular Center, Budapest, Hungary
| | - E Merkel
- Semmelweis University Heart and Vascular Center, Budapest, Hungary
| | - W Schwertner
- Semmelweis University Heart and Vascular Center, Budapest, Hungary
| | - B Veres
- Semmelweis University Heart and Vascular Center, Budapest, Hungary
| | - A Behon
- Semmelweis University Heart and Vascular Center, Budapest, Hungary
| | - A Pinter
- Semmelweis University Heart and Vascular Center, Budapest, Hungary
| | - I Osztheimer
- Semmelweis University Heart and Vascular Center, Budapest, Hungary
| | - E Zima
- Semmelweis University Heart and Vascular Center, Budapest, Hungary
| | - L Geller
- Semmelweis University Heart and Vascular Center, Budapest, Hungary
| | - D Becker
- Semmelweis University Heart and Vascular Center, Budapest, Hungary
| | - A Kosztin
- Semmelweis University Heart and Vascular Center, Budapest, Hungary
| | - B Merkely
- Semmelweis University Heart and Vascular Center, Budapest, Hungary
| |
Collapse
|
41
|
Bengel PRF, Kessel B, Schloegl S, Bauer A, Junttila J, Lubinski A, Malik M, Merkely B, Schmidt G, Svendsen JH, Vos MA, Willems R, Sticherling C, Friede T, Zabel M. QRS duration as an independent risk factor for appropriate shocks and mortality in patients with prophylactic implantable cardioverter-defibrillator. Europace 2022. [DOI: 10.1093/europace/euac053.388] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Funding Acknowledgements
Type of funding sources: Public grant(s) – EU funding. Main funding source(s): European Community’s 7th Framework Programme FP7/2007-2013
Background
The implantable cardioverter defibrillator (ICD) is an established therapy for the prevention of sudden cardiac death (SCD) in high-risk heart failure patients. However, improvements in risk stratification are necessary to increase the efficiency of ICD use. We performed an analysis of the retrospective EU-CERT-ICD registry with respect to QRS duration and effects of cardiac resynchronisation therapy (CRT) on outcomes.
Methods/Results
A total of 5033 patients (81% males) from 14 European centres had an ICD implanted for primary prophylaxis. Mean age at the time of ICD implantation was 64±11 years and ischemic cardiomyopathy was the underlying pathology in 65% of patients. CRT was used in 43% of the patients. The median follow-up was 2.7 years (IQR 1.4-4.6 years). Predefined primary endpoints were all-cause mortality, first appropriate and first inappropriate shocks. The effect of covariates on the cumulative primary endpoints were assessed through hazard ratios in the Fine and Gray subdistributional hazard models (accounting for the competing risks) stratified by centres.
Because of resynchronization by the device, the analysis considered a different influence of QRS on outcomes in the CRT-D and the ICD groups. We observed an increase in the cumulative incidence of the first appropriate shock with increasing QRS values for patients implanted with only an ICD (HR 1.12 per 10ms increase, p<0.001). In patients with CRT-D, increasing QRS values related to a (statistically non-significant) decrease in the cumulative incidence of the first appropriate shocks (HR 0.96 per 10ms, p=0.299).
Since a wide QRS is an indication for CRT-D therapy, high QRS values cluster among those patients with implanted CRT-D, while among patients with QRS under 130ms standard ICD implantations are more frequent. This can explain the observed increase in the cumulative incidence of the first appropriate shocks for increasing QRS values up to 130ms in the ICD-group and its decrease for increasing QRS values over 130ms in the CRT-D group.
Regarding all-cause mortality, hazard ratios for age, LVEF, NYHA, ICM, AF, diabetes and sex category agreed with the results obtained in previously published meta-analyses.
Increased QRS values are associated with higher mortality in the ICD group (HR 1.09 per 10ms increase, p<0.001), but not in the CRT-D group (HR 0.99 per 10ms increase, p=0.695).
Conclusion
In our study, we confirmed QRS duration as an independent risk factor for appropriate ICD shocks and all-cause mortality in patients with ICD for primary prophylaxis. However, this was only observed in patients with single- or dual-chamber ICD, while there was no correlation in CRT-D patients. The findings suggest that CRT-D exerts a protective effect regarding the occurrence of first appropriate shock and all-cause mortality for patients with QRS values higher than 130 ms and indication for resynchronization.
Collapse
Affiliation(s)
- PRF Bengel
- University Medical Center Gottingen (UMG), Department for Cardiology and Pneumology, Gottingen, Germany
| | - B Kessel
- Helmholtz Centre for Infection Research, Braunschweig, Germany
| | - S Schloegl
- University Medical Center Gottingen (UMG), Department for Cardiology and Pneumology, Gottingen, Germany
| | - A Bauer
- Medical University of Innsbruck, Dept. of Cardiology, Innsbruck, Austria
| | - J Junttila
- Medical Research Center Oulu, Oulu, Finland
| | - A Lubinski
- Medical University of Lodz, Dept. of Cardiology, Lodz, Poland
| | - M Malik
- Imperial College London, National Heart and Lung Institute, London, United Kingdom of Great Britain & Northern Ireland
| | - B Merkely
- Semmelweis University Heart and Vascular Center, Budapest, Hungary
| | - G Schmidt
- Technical University of Munich, Med. Klinik und Poliklinik I, Klinikum rechts der Isar, Munich, Germany
| | - JH Svendsen
- Rigshospitalet - Copenhagen University Hospital, Dept. of Cardiology, The Heart Centre, Copenhagen, Denmark
| | - MA Vos
- University Medical Center Utrecht, Dept. of Medical Physiology, Utrecht, Netherlands (The)
| | - R Willems
- University Hospitals Leuven, Leuven, Belgium
| | - C Sticherling
- University Hospital Basel, Department of Cardiology, Basel, Switzerland
| | - T Friede
- University Medical Center of Gottingen (UMG), Department of Medical Statistics, Goettingen, Germany
| | - M Zabel
- University Medical Center Gottingen (UMG), Department for Cardiology and Pneumology, Gottingen, Germany
| |
Collapse
|
42
|
Maglia G, Hindricks G, Theuns DA, Bar-Lev D, Anguera I, Ayala Paredes FA, Arnold M, Geller JC, Merkely B, Dyrda KM, Perings C, Ploux S, Meyhoefer J, Timmel T, Bollmann A. Capability of guideline-conform remote atrial high rate episode monitoring with a single-chamber implantable defibrillator with atrial sensing. Europace 2022. [DOI: 10.1093/europace/euac053.515] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Funding Acknowledgements
Type of funding sources: Private company. Main funding source(s): BIOTRONIK, Berlin, Germany
Introduction
Device-detected atrial high-rate episodes (AHRE) and their burden progression are associated with an increased risk for thromboembolic events in correlation with CHA2DS2-VASc score and AHRE burden. To allow timely initiation of anticoagulation therapy for the prevention of stroke, the European guidelines on atrial fibrillation (AF) recommend the monitoring of AHRE progression along pre-specified strata (6min…<1h, 1h…<24, ≥24h). We sought to assess the capability of a single-lead implantable cardioverter defibrillator (ICD), that is equipped with an atrial dipole for atrial sensing, to remotely detect and monitor AHRE burden progression in patients with standard indication to single-chamber ICD.
Methods
From the MATRIX (Management and Detection of Atrial Tachyarrhythmias in Patients Implanted With BIOTRONIK DX Systems) registry, we analyzed remotely transmitted, and electrogram (IEGM) AHREs in a subset of patients with remote transmissions and without history of long-standing AF at baseline. For each patient, we selected the first occurring episode per duration stratum and the first subsequent occurrence when progressing to a stratum of any longer duration. After episode adjudication by an independent electrophysiologist, we assessed the classification performance of the device (positive predictive value [PPV]) and analyzed AHRE onset and progression pathways.
Results
Of the MATRIX cohort, 1,746 patients matched the inclusions criteria (see table for patient characteristics) and 1,451 had no AF history. Of the 258 patients with AHREs (14.8%), 450 out of 465 evaluated episodes were correctly classified as AHRE. Reasons for misclassification were artifact (13) and R-wave oversensing (2). PPV was 96.8% (95% confidence interval 94.7%-98.2%). Grouped by stratum, PPV was 93.9%, 99.5% and 100% for 6min…<1h, 1h…<24 and ≥24h, respectively. Ninety six of 240 patients (40.0%) with a first episode according to the pre-specified strata were progressing to a stratum of longer duration and 9 patients (3.8%) had further progression (see Figure). In 119 out of 1,451 patients without AF history (8.2%), the device detected AHRE and 81 of them (4.6% of analysis set) had a mid to high risk for stroke and were not on anticoagulation therapy. In 121 out of 295 patients with known history of paroxysmal and persistent AF (41.0%), the arrhythmia was confirmed by the device.
Discussion and Conclusion: The single-chamber ICD with atrial sensing capabilities correctly classified ≈97% of all adjudicated AHREs ≥6min. About 7% of patients had device-detected AHRE onset and/or progression and a mid to high stroke risk. These patients would potentially benefit the most from a guideline-conform AF monitoring strategy to timely initiate anticoagulation medication for stroke prevention.
Collapse
Affiliation(s)
- G Maglia
- Azienda Ospedaliera Pugliese-Ciaccio, Catanzaro, Italy
| | - G Hindricks
- Heart Center of Leipzig, Department of Electrophysiology, Leipzig, Germany
| | - DA Theuns
- Erasmus University Medical Centre, Rotterdam, Netherlands (The)
| | - D Bar-Lev
- Chaim Sheba Medical Center, Tel Hashomer, Israel
| | - I Anguera
- University Hospital of Bellvitge, Heart Diseases Institute, Barcelona, Spain
| | | | - M Arnold
- University hospital Erlangen, Erlangen, Germany
| | - JC Geller
- Central Clinic Bad Berka, Bad Berka, Germany
| | - B Merkely
- Semmelweis University, Budapest, Hungary
| | - KM Dyrda
- University of Montreal, Montreal Heart Institute, Montreal, Canada
| | - C Perings
- St.-Marien-Hospital, Luenen, Germany
| | - S Ploux
- Haut-Leveque Hospital - University Hospital Centre, Pessac, France
| | - J Meyhoefer
- Maria Heimsuchung Caritas-Clinic Pankow, Berlin, Germany
| | - T Timmel
- Biotronik SE & Co. KG, Berlin, Germany
| | - A Bollmann
- Heart Center of Leipzig, Department of Electrophysiology, Leipzig, Germany
| |
Collapse
|
43
|
Szabo L, Dohy Z, Juhasz V, Balla D, Kiss AR, Gregor Z, Szucs A, Babity M, Kiss O, Csulak E, Sydo N, Hirschberg K, Merkely B, Vago H. How native T1 and T2 mapping is influenced by sex and training load? Cardiac magnetic resonance imaging in young elite athletes and less active individuals. Eur J Prev Cardiol 2022. [DOI: 10.1093/eurjpc/zwac056.266] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022]
Abstract
Abstract
Funding Acknowledgements
Type of funding sources: Other. Main funding source(s): This study was financed by the Ministry of Innovation and Technology NRDI Office within the framework of the Artificial Intelligence National Laboratory Program. LS is supported by the EACVI Research Grant 2021.
Introduction
Cardiac adaptation due to regular and intense exercise is a well-known phenomenon. Cardiac magnetic resonance (CMR) imaging is a well suited, highly reproducible technique that has a vital role in differentiating physiological adaptation and pathological alterations. Native T1 and T2 mapping enable the quantitative assessment of tissue characteristics without the administration of contrast material. These techniques are increasingly used in studies aiming to consider subtle differences. However, the sex-and training-dependence of native T1 and T2 mapping values remains incompletely understood.
Purpose
We aimed to describe the differences in native T1 and T2 mapping among healthy athletes and less active individuals.
Methods
We enrolled healthy elite athletes (n=88, 56 male, 25±5 years) and healthy volunteers (n=82, 46 male, 25±3 years) to undergo CMR examinations at our Centre. Healthy elite athletes performed high sports activity levels (>10 hours/week) and competed nationally or internationally. Sex- and age-matched healthy volunteers engaged in ≤6 hours/week of sports activity. Standardized CMR protocol included short- and long-axis cine images covering the entire left (LV) and right (RV) ventricle and native T1 and T2 mapping in basal, midventricular and apical slices.
Results
Athletes had consistently higher LV and RV volumes and mass indexes compared to healthy volunteers (p<.001 for all). Native T1 mapping was lower in athletes than in the control group (T1: 954±24 ms vs 970±23 ms; p <.001). T1 mapping showed a moderately strong negative correlation to markers of cardiac adaptation, including LV mass, end-diastolic volume and stroke volume indexes (p<.001 for all). Moreover, we found a negative correlation between native T1 and training hours (Rho: -0.302; p<.001). On the other hand, native T2 mapping showed no difference between athletes and less active controls. Furthermore, T2 correlated with LV shape features but not with training hours. We found that mapping values differed between sexes, both in the athletic and control groups. Females showed slightly higher values compared to their male counterparts (T2: 46±2 vs 43±2; p<.001). Finally, native T1 mapping was associated with training hours and sex in our multiple linear regression model, adjusted for age, resting heart rate, body mass index, body surface area and LVM (p<.001). While T2 mapping was associated only with sex considering the same covariates.
Conclusion
Our study demonstrates the importance of sex-matched controls in CMR studies evaluating mapping parameters. Moreover, the consideration of exercise load seems paramount in the case of T1 mapping.
Collapse
Affiliation(s)
- L Szabo
- Semmelweis University Heart and Vascular Center, Budapest, Hungary
| | - Z Dohy
- Semmelweis University Heart and Vascular Center, Budapest, Hungary
| | - V Juhasz
- Semmelweis University Heart and Vascular Center, Budapest, Hungary
| | - D Balla
- Semmelweis University Heart and Vascular Center, Budapest, Hungary
| | - A R Kiss
- Semmelweis University Heart and Vascular Center, Budapest, Hungary
| | - Z Gregor
- Semmelweis University Heart and Vascular Center, Budapest, Hungary
| | - A Szucs
- Semmelweis University Heart and Vascular Center, Budapest, Hungary
| | - M Babity
- Semmelweis University Heart and Vascular Center, Budapest, Hungary
| | - O Kiss
- Semmelweis University, Faculty of Cardiology and Sports Medicine, Budapest, Hungary
| | - E Csulak
- Semmelweis University Heart and Vascular Center, Budapest, Hungary
| | - N Sydo
- Semmelweis University, Faculty of Cardiology and Sports Medicine, Budapest, Hungary
| | - K Hirschberg
- Semmelweis University Heart and Vascular Center, Budapest, Hungary
| | - B Merkely
- Semmelweis University, Faculty of Cardiology and Sports Medicine, Budapest, Hungary
| | - H Vago
- Semmelweis University, Faculty of Cardiology and Sports Medicine, Budapest, Hungary
| |
Collapse
|
44
|
Teszák T, Király Á, Hartyánszky I, Müllner K, Tajti B, Merkely B, Sax B. Intractable Gastrointestinal Bleeding Events After Left Ventricular Assist Device Implantation. J Heart Lung Transplant 2022. [DOI: 10.1016/j.healun.2022.01.1195] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022] Open
|
45
|
Szucs A, Kiss AR, Gregor ZS, Furak A, Szabo LE, Dohy ZS, Grebur K, Merkely B, Vago H. Age- and sex-specific characteristics of right ventricular compacted and trabeculated myocardium by cardiac magnetic resonance. Eur Heart J Cardiovasc Imaging 2022. [DOI: 10.1093/ehjci/jeab289.338] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Abstract
Abstract
Funding Acknowledgements
Type of funding sources: Public grant(s) – National budget only. Main funding source(s): Ministry for Innovation and Technology in Hungary within the framework of the Therapeutic Development and Bioimaging Programs of Semmelweis University. National Research, Development and Innovation Fund of Hungary, financed under the NVKP_16 funding scheme.
The sex-specific characteristics of right ventricular compacted (RV-CM) and RV-trabeculated myocardial mass (RV-TM) over time and the determinants of RV myocardium are less well studied; however, in different conditions, these might provide additional information to the diagnosis.
We aimed to describe the age- and sex-specific characteristics of RV-CMi, RV-TMi, and RV volumetric and functional parameters and investigate the determinants of RV myocardial mass with CMR.
Two hundred healthy Caucasian volunteers free of known cardiovascular or systemic diseases were enrolled in this study. Four different age groups were established with equal numbers of males and females: Group A (n = 50, 20-29 years, mean age: 24.3 ± 3.2 years), Group B (n = 50, 30-39 years, mean age: 33.6 ± 2.6 years), Group C (n = 50, 40-49 years, mean age: 44.7 ± 2.7 years), and Group D (n = 50, ≥ 50 years, mean age: 55.1 ± 3.9 years). RV volumetric and functional, RV-CMi and RV-TMi values were measured with a threshold-based postprocessing method for CMR.
The volumetric parameters, RV-CMi, and RV-TMi were larger in males, and the ejection fraction (EF) was higher in females. The RV-CMi did not correlate with age in either of the sexes, while the RV-TMi decreased with age in females but remained stable in males. The RV-TMi and RV-CMi correlated positively with RV volumetric parameters, the left ventricular (LV)-CMi, the LV-TMi, and each other in both sexes. LV-TMi, LV-CMi, RV end-systolic volume, and sex were independent predictors of RV-TMi.
Understanding the natural history of RV-trabeculated and RV-compacted myocardium might have additive value in diagnosing different conditions with RV hypertrophy or hypertrabeculation.
Collapse
Affiliation(s)
- A Szucs
- Semmelweis University Heart and Vascular Center, Budapest, Hungary
| | - AR Kiss
- Semmelweis University Heart and Vascular Center, Budapest, Hungary
| | - ZS Gregor
- Semmelweis University Heart and Vascular Center, Budapest, Hungary
| | - A Furak
- Semmelweis University Heart and Vascular Center, Budapest, Hungary
| | - LE Szabo
- Semmelweis University Heart and Vascular Center, Budapest, Hungary
| | - ZS Dohy
- Semmelweis University Heart and Vascular Center, Budapest, Hungary
| | - K Grebur
- Semmelweis University Heart and Vascular Center, Budapest, Hungary
| | - B Merkely
- Semmelweis University Heart and Vascular Center, Budapest, Hungary
| | - H Vago
- Semmelweis University Heart and Vascular Center, Budapest, Hungary
| |
Collapse
|
46
|
Gregor Z, Kiss AR, Grebur K, Szabo LE, Merkely B, Vago H, Szucs A. MR -specific characteristics of left ventricular noncompaction and dilated cardiomyopathy. Eur Heart J Cardiovasc Imaging 2022. [DOI: 10.1093/ehjci/jeab289.428] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Funding Acknowledgements
Type of funding sources: Public grant(s) – National budget only. Main funding source(s): Thematic Excellence Programme (Tématerületi Kiválósági Program, 2020-4.1.1.-TKP2020) of the Ministry for Innovation and Technology in Hungary within the framework of the Therapeutic Development and Bioimaging Programs of Semmelweis University Development of Scientific Workshops of Medical, Health Sciences and Pharmaceutical Edication (Project identification number: EFOP- 3.6.3-VEKOP-16- 2017-00009) Project no. NVKP_16-1–2016-0017 (’National Heart Program’) has been implemented with the support provided from the National Research, Development and Innovation Fund of Hungary, financed under the NVKP_16 funding scheme. The research was supported by the Ministry of Innovation and Technology NRDI Office within the framework of the Artificial Intelligence National Laboratory Program.
The differentiation of dilated cardiomyopathy (DCM) and left ventricular noncompaction
(LVNC) is a recurring issue during cardiac imaging processes; thus, we aimed to compare the
left ventricular (LV) cardiac MRI (CMR) characteristics of DCM and LVNC patients.
Thirty-one nonischemic DCM patients, 42 LVNC patients with reduced EF and 42 healthy
controls were included in this retrospective study. The LV volumetric, functional and
myocardial mass parameters were measured with a threshold-based technique, while global
and segmental strain values and rotational patterns were analyzed with feature-tracking
strain analysis.
Of the LV volumetric and myocardial mass parameters, only the trabeculated and papillary
muscle mass (TPMi) values differed significantly between the patient groups and were higher
in the LVNC group compared to DCM (DCM vs LVNC: 43.2 ± 8.9 vs 51.6 ± 13.6 g/m2, p < 0.002).
The global longitudinal and circumferential strains were similar between the patient groups
and significantly worse than those of the controls. In comparing the segmental strain values
between the patient groups, only the circumferential apical strain was significantly lower in
the LVNC group (DCM vs LVNC: -30.5 ± 13.5 vs -24.5 ± 12.0%, p < 0.05). There was no difference
in the rotational pattern between the patient groups, and both the healthy and patient
populations showed heterogeneous rotational patterns.
Despite the similarities of DCM and LVNC in volumetric, global strain parameters, and
rotational patterns, we found some morphological and functional differences between the
patient groups. These minor alterations might be due to the morphological characteristics of
LVNC with a trabeculated apical region.
Collapse
Affiliation(s)
- Z Gregor
- Semmelweis University Heart and Vascular Center, Budapest, Hungary
| | - AR Kiss
- Semmelweis University Heart and Vascular Center, Budapest, Hungary
| | - K Grebur
- Semmelweis University Heart and Vascular Center, Budapest, Hungary
| | - LE Szabo
- Semmelweis University Heart and Vascular Center, Budapest, Hungary
| | - B Merkely
- Semmelweis University Heart and Vascular Center, Budapest, Hungary
| | - H Vago
- Semmelweis University Heart and Vascular Center, Budapest, Hungary
| | - A Szucs
- Semmelweis University Heart and Vascular Center, Budapest, Hungary
| |
Collapse
|
47
|
Molnar AA, Abraham P, Gulyas G, Meszaros H, Pasztor D, Straub E, Nardai S, Merkely B. Size of transcatheter patent foramen ovale closure device affects atrial function. Eur Heart J Cardiovasc Imaging 2022. [DOI: 10.1093/ehjci/jeab289.327] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Funding Acknowledgements
Type of funding sources: None.
Introduction
Interatrial communications such as patent foramen ovale (PFO) are common abnormalities. For most people they are accidental findings; however, in some cases lead to paradoxical embolization. Transcatheter closure of PFO in patients with cryptogenic stroke is associated with reduced rates of recurrent stroke. The size of closure device is established according to anatomical features of atria. However, the impact of atrial septal closure on atrial remodelling is less known.
Methods
We prospectively enrolled 108 patients with cryptogenic ischemic stroke and PFO eligible for transcatheter PFO closure. Thirty-three patients had 6 month clinical follow-up examinations (mean age 46 ± 13 years, 34% females). National Institute of Health Stroke Score (NIHSS) was calculated as marker of clinical severity of the index stroke. Presence of any shunt, atrial volumes and functional parameters were evaluated including left atrial (LA) reservoir, conduit and contraction function before PFO closure and 6 months after procedure. Beyond conventional transthoracic echocardiography (Philips Epiq CVx Ultrasound), two dimensional speckle tracking method was used to assess body surface area-indexed LA maximal volume (LAVmaxi), LA minimal volume (LAVmini), LA volume before left atrial contraction (LApreAi), LA ejection fraction (LAEF), LA reservoir strain (LASres), LA conduit strain (LAScond), LA contraction strain (LAScontr), LA peak systolic strain rates (LASRs), LA peak early diastolic strain rate (LASRe) and LA peak late diastolic strain rate (LASRa) using dedicated software on separate workstation (Cardiac Performance; TomTec Imaging, Unterschleissheim, Germany). Zero reference point was set at the onset of QRS wave.
Results
The index stroke was modest and non-disabling, with an NIHSS 3.2 ± 2.6. Baseline LA volumes and functions were in normal range (LAVi 27.4 ± 10.3 ml/m2; LASres 46.85 ± 19.6 %; LAScond 25.6 ± 15.4%; LAScontr 21.35 ± 12.15 %; LASRa -1.9 ± 0.77 s-1). The 6 month clinical follow-up examinations revealed no significant differences (all p values >0.05) in atrial volumes and strain parameters. However, LASRa was significantly lower (-1.4 ± 0.82 s-1, p = 0.01). Closure device size (25mm vs 30mm) and smoking proved to be independent predictors of 25% decrease of LASRa (p = 0.06, p = 0.03, respectively). No new cerebral ischaemic events, aortic erosions, atrial fibrillation, significant residual shunts or device thrombosis and displacement were recorded during the follow-up.
Conclusion
PFO-associated strokes in young and middle-aged individuals are mainly non-disabling. Transcatheter interatrial closure was safe and effective in our study without promoting unfavourable anatomical atrial remodelling during short-term follow-up, however, it may affect active atrial contraction. Smoking and larger devices may decrease the rate of atrial deformation at short-term follow-up. Shorter PFO occluders are preferable in case of anatomical applicability.
Collapse
Affiliation(s)
- AA Molnar
- Semmelweis University Heart and Vascular Center, Budapest, Hungary
| | - P Abraham
- Semmelweis University Heart and Vascular Center, Budapest, Hungary
| | - G Gulyas
- Semmelweis University Heart and Vascular Center, Budapest, Hungary
| | - H Meszaros
- Semmelweis University Heart and Vascular Center, Budapest, Hungary
| | - D Pasztor
- Semmelweis University Heart and Vascular Center, Budapest, Hungary
| | - E Straub
- Semmelweis University Heart and Vascular Center, Budapest, Hungary
| | - S Nardai
- Semmelweis University Heart and Vascular Center, Budapest, Hungary
| | - B Merkely
- Semmelweis University Heart and Vascular Center, Budapest, Hungary
| |
Collapse
|
48
|
Fabian A, Ujvari A, Tokodi M, Lakatos BK, Eles Z, Kiss O, Babity M, Sydo N, Csulak E, Vago H, Szabo L, Kiss A, Szucs A, Merkely B, Kovacs A. Biventricular mechanical pattern of the athlete"s heart: comprehensive characterization using 3D echocardiography. Eur Heart J Cardiovasc Imaging 2022. [DOI: 10.1093/ehjci/jeab289.130] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Funding Acknowledgements
Type of funding sources: None.
Regular, intense exercise results in complex morphological and functional cardiac remodeling, commonly referred to as the athlete"s heart. While left ventricular (LV) adaptation is thoroughly studied, data are scarce concerning the right ventricular (RV) mechanical changes and their continuum with exercise performance.
Accordingly, our aim was to characterize biventricular morphology and function and its relation to sex, age and sport classes in a large cohort of elite athletes using 3D echocardiography.
Four hundred and twenty-two elite, competitive athletes (male/female: 295/127, adult/adolescent: 207/215) from the 4 major sport classes (mixed type n = 293; endurance n = 88; power n = 33; skill n = 8) and healthy, sedentary volunteers (n = 55) were enrolled. 3D transthoracic echocardiographic datasets were acquired to quantify LV and RV end-diastolic volumes (EDVi), and ejection fractions (EF). In order to characterize biventricular mechanical parameters, LV and RV global longitudinal (GLS) and global circumferential strains (GCS) were measured using dedicated softwares. Additionally, all subjects underwent cardiopulmonary exercise testing in order to determine peak oxygen uptake (VO2/kg).
Athletes had significantly higher LV and RV EDVi compared with controls, whereas male athletes had larger volumes than female athletes, and adult athletes had also larger LV EDVi than adolescent athletes (all p < 0.05). However, RV EDVi was similar between the two age groups. Endurance athletes had significantly larger RV EDVi compared with the other sport classes (ANOVA p < 0.05).
Concerning biventricular functional parameters, athletes had significantly lower resting LV and RV EF (athletes vs. controls; LVEF: 57 ± 4 vs. 61 ± 5%; RVEF: 55 ± 5 vs. 59 ± 5%; p < 0.001) as well as LV GLS (-19.2 ± 2.3 vs. -21.2 ± 2.0%), LV GCS (-27.7 ± 3.0 vs. -31.0 ± 3.5%), and RV GCS (-20.9 ± 4.4 vs. -24.5 ± 4.5%; all p < 0.001) compared with controls. In contrast, RV GLS (-21.8 ± 3.4 vs. -22.2 ± 3.6%) did not differ between athletes and controls. The exercise-induced relative decrease in LV GLS (9.5 ± 10.7%) and LV GCS (10.7 ± 9.8%) was similar, however, the decrement in RV GCS (14.8 ± 17.8%) was disproportionately larger compared with RV GLS (1.7 ± 15.4%, p < 0.01) in the athlete population. By multivariable linear regression analysis among echocardiographic parameters using ordinary least squares, RVEDVi was found to be the strongest and independent predictor of VO2/kg, followed by RV GCS and LV EDVi.
Regular physical exercise results in significant and specific changes in LV and RV geometry and function. Resting LV mechanics of the athlete"s heart is characterized by a balanced decrement in GLS and GCS, however, in the RV the circumferential shortening decreases disproportionately compared with the longitudinal shortening. Moreover, this mechanical pattern is associated with better exercise capacity, which emphasizes the importance of the RV in determining athletic performance.
Collapse
Affiliation(s)
- A Fabian
- Semmelweis University, Heart and Vascular Center, Budapest, Hungary
| | - A Ujvari
- Semmelweis University, Heart and Vascular Center, Budapest, Hungary
| | - M Tokodi
- Semmelweis University, Heart and Vascular Center, Budapest, Hungary
| | - BK Lakatos
- Semmelweis University, Heart and Vascular Center, Budapest, Hungary
| | - Z Eles
- Semmelweis University, Heart and Vascular Center, Budapest, Hungary
| | - O Kiss
- Semmelweis University, Department of Sports Medicine, Budapest, Hungary
| | - M Babity
- Semmelweis University, Heart and Vascular Center, Budapest, Hungary
| | - N Sydo
- Semmelweis University, Department of Sports Medicine, Budapest, Hungary
| | - E Csulak
- Semmelweis University, Heart and Vascular Center, Budapest, Hungary
| | - H Vago
- Semmelweis University, Department of Sports Medicine, Budapest, Hungary
| | - L Szabo
- Semmelweis University, Heart and Vascular Center, Budapest, Hungary
| | - A Kiss
- Semmelweis University, Heart and Vascular Center, Budapest, Hungary
| | - A Szucs
- Semmelweis University, Heart and Vascular Center, Budapest, Hungary
| | - B Merkely
- Semmelweis University, Department of Sports Medicine, Budapest, Hungary
| | - A Kovacs
- Semmelweis University, Heart and Vascular Center, Budapest, Hungary
| |
Collapse
|
49
|
Boussoussou M, Szilveszter B, Vattay B, Kolossvary M, Vecsey-Nagy M, Sallo Z, Maurovich-Horvat P, Merkely B, Geller L, Szegedi N. A new perspective to evaluate CLOSE protocol by coronary CT angiography including the evaluation of left atrial wall thickness. Eur Heart J Cardiovasc Imaging 2022. [DOI: 10.1093/ehjci/jeab289.336] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
Abstract
Abstract
Funding Acknowledgements
Type of funding sources: Public grant(s) – National budget only. Main funding source(s): This study was supported by the National Research, Development and Innovation Office of Hungary (NKFIA; NVKP_16-1-2016-0017 National Heart Program). The research was supported by the Thematic Excellence Programme (Tématerületi Kiválósági Program, 2020-4.1.1.-TKP2020) of the Ministry for Innovation and Technology in Hungary, within the framework of the Therapeutic Development and Bioimaging programmes of the Semmelweis University. The project was supported by the KH-17 Programme of the National Research, Development and Innovation Office of the Ministry of Innovation and Technology in Hungary (NKFIH). Bálint Szilveszter MD PhD was supported by the ÚNKP-20-4-II New National Excellence Program of the Ministry for Innovation and Technology from the source of the National research, Development and Innovation fund. M. Boussoussou and B. Vattay were supported by the “NTP-NFTÖ” (Nemzeti Tehetség Program, Nemzet Fiatal Tehetségeiért Ösztöndíj) program of the Ministry of Human Capacities in Hungary (EMMI) and by the EFOP-3.6.3-VEKOP-16-2017-00009.
Introduction
The CLOSE protocol is a novel contact-force guided technique for enclosing pulmonary veins in patients with atrial fibrillation (AF). We sought to determine whether left atrial (LA) wall thickness (LAWT) and pulmonary vein (PV) dimensions as assessed by coronary CT angiography (CTA) could influence the efficacy of successful first-pass isolation using the CLOSE protocol. Methods: In a single center, prospective study we enrolled 94 patients with symptomatic, drug-refractory AF who underwent pre-ablation left atrial CTA and initial radiofrequency catheter ablation between 2019.01-2020.09. The LA was divided into 11 regions when assessing LAWT. Additionally, the diameter and area of the PV orifices were obtained. First pass isolation was recorded separately for the right and left PVs. After the first-pass ablation circles were ready, additional ablations were applied in those cases where first pass isolation was not achieved, to reach complete PV isolation. Predictors of successful first pass isolation were determined using logistic regression models that included anthropometrical, echocardiographic and CTA derived parameters. Results: A total of 94 patients were included in the analysis with mean CHA2DS2-VASc score of 2.1 ± 1.5 (mean age 62.4 ± 12.6 years, 39.5% female). 61.7 % were paroxysmal, 38.3 were persistent AF patients. First-pass isolation rate was 76%, 71% and 54%, for the right PVs, left PVs and all four PVs, respectively. No difference was found regarding comorbidities and imaging parameters between those with and without first-pass isolation. LAWT (mean of all 11 regions or separately) had no effect on the procedural outcome (all p >0.05). Mean procedure times were 81.2 ± 19.3 minutes. Complete isolation of all four PVs was achieved in 100% of patients. Out of all assessed parameters, only RSPV diameter was associated with right sided successful PVI on first pass isolation (p = 0.04, OR 1.01). Conclusion: The use of CLOSE protocol in AF patients resulted in high periprocedural success rate in terms of first pass isolation, independently from the thickness of the LA wall. RSPV diameter could influence the results of first pass isolation.
Collapse
Affiliation(s)
- M Boussoussou
- Semmelweis University Heart and Vascular Center, Budapest, Hungary
| | - B Szilveszter
- Semmelweis University Heart and Vascular Center, Budapest, Hungary
| | - B Vattay
- Semmelweis University Heart and Vascular Center, Budapest, Hungary
| | - M Kolossvary
- Semmelweis University Heart and Vascular Center, Budapest, Hungary
| | - M Vecsey-Nagy
- Semmelweis University Heart and Vascular Center, Budapest, Hungary
| | - Z Sallo
- Semmelweis University Heart and Vascular Center, Budapest, Hungary
| | | | - B Merkely
- Semmelweis University Heart and Vascular Center, Budapest, Hungary
| | - L Geller
- Semmelweis University Heart and Vascular Center, Budapest, Hungary
| | - N Szegedi
- Semmelweis University Heart and Vascular Center, Budapest, Hungary
| |
Collapse
|
50
|
Grebur K, Gregor ZS, Kiss AR, Szabo LE, Toth A, Horvath M, Dohy ZS, Merkely B, Vago H, Szucs A. Sex- and age- specific normal values with threshold-based trabeculae quantification. Eur Heart J Cardiovasc Imaging 2022. [DOI: 10.1093/ehjci/jeab289.330] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Funding Acknowledgements
Type of funding sources: Public grant(s) – National budget only. Main funding source(s): ÚNKP-19-3-II New National Excellence Program of the Ministry for Innovation and Technology National Research, Development and Innovation Office of Hungary (NKFIA; NVKP_16-1-2016-0017 National Heart Program) Thematic Excellence Program (Tématerületi Kiválósági Program 2020-4.1.1-TKP2020)
The threshold-based (TB) trabeculated and papillary muscle mass (TPM) quantification method for cardiac MRI (CMR) calculates different values than conventional contouring techniques.
We aimed to identify the sex- and age-related normal reference ranges for left ventricular (LV) myocardial mass values, volumetric and functional parameters and the correspondence of these parameters using the TB method.
Healthy European adults (n = 200, age: 39.4 ± 12 years, males: 100) were examined with CMR and evaluated with a TB postprocessing method. They were stratified by sex and age (Group A: 18-29, Group B: 30-39, Group C: 40-49, Group D: >50 years). The calculated parameters were indexed to body surface area (i).
The normal reference ranges for the studied parameters were assessed in each age group. Significant biometric differences in LV parameters and mass-to-volume ratios were found between males and females, and the left ventricular compacted myocardial mass (LVCMi) and TPMi differences remained significant after stratification by age. Unlike other LV volumetric and functional parameters and mass-to-volume ratios, the TPMi, the LVCMi and the TPMi-to-LVCMi ratio did not differ among age groups in males or females. This finding was strengthened by the lack of correlation between TPMi and age.
Age- and sex-related normal reference ranges for LV volumetric and functional parameters and LVCMi and TPMi values were established using a TB postprocessing method. TPMi, LVCMi and their ratio did not change over time. The TPMi-to-LVCMi and the mass-to-volume ratios might have clinical utility in the differential diagnosis of conditions with LV hypertrabeculation.
Collapse
Affiliation(s)
- K Grebur
- Semmelweis University, Budapest, Hungary
| | - ZS Gregor
- Semmelweis University, Budapest, Hungary
| | - AR Kiss
- Semmelweis University, Budapest, Hungary
| | - LE Szabo
- Semmelweis University, Budapest, Hungary
| | - A Toth
- Semmelweis University, Budapest, Hungary
| | - M Horvath
- Semmelweis University, Budapest, Hungary
| | - ZS Dohy
- Semmelweis University, Budapest, Hungary
| | - B Merkely
- Semmelweis University, Budapest, Hungary
| | - H Vago
- Semmelweis University, Budapest, Hungary
| | - A Szucs
- Semmelweis University, Budapest, Hungary
| |
Collapse
|